<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Trop Med Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">Trop Med Infect Dis</journal-id><journal-id journal-id-type="publisher-id">tropicalmed</journal-id><journal-title-group><journal-title>Tropical Medicine and Infectious Disease</journal-title></journal-title-group><issn pub-type="epub">2414-6366</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39998060</article-id><article-id pub-id-type="pmc">PMC11860780</article-id>
<article-id pub-id-type="doi">10.3390/tropicalmed10020056</article-id><article-id pub-id-type="publisher-id">tropicalmed-10-00056</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Assessing the Impact of Air Quality and Socioeconomic Conditions on Respiratory Disease Incidence</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Alkhanani</surname><given-names>Mustfa Faisal</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Smith</surname><given-names>David W.</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Ali</surname><given-names>Sheikh Taslim</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Kersey</surname><given-names>Jing X.</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Li</surname><given-names>Li</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-tropicalmed-10-00056">Biology Department, College of Science, University of Hafr Al Batin, P.O. Box 1803, Hafr Al Batin 39524, Saudi Arabia; <email>mfalkhanani@uhb.edu.sa</email></aff><pub-date pub-type="epub"><day>17</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>10</volume><issue>2</issue><elocation-id>56</elocation-id><history><date date-type="received"><day>03</day><month>1</month><year>2025</year></date><date date-type="rev-recd"><day>06</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>11</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the author.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><bold>Background and Objective:</bold> Air pollution poses significant risks to global public health and has well-established links to respiratory diseases. This study investigates the associations between air pollution markers&#x02014;Air Quality Index (AQI), ambient ozone, and nitrogen dioxide (NO<sub>2</sub>)&#x02014;and the incidence of chronic obstructive pulmonary disease (COPD), asthma, and tuberculosis. It also examines how socioeconomic factors such as gross domestic product (GDP) per capita, tobacco prevalence, and healthcare expenditure influence these relationships. This study includes data from 27 countries, thereby offering a global perspective to inform public health interventions and policy reforms. <bold>Methods:</bold> Data on average air pollution levels, respiratory disease incidence, and socioeconomic factors were collected from publicly available sources spanning four years. The 27 countries included in the study were selected to represent a broad range of pollution levels, income brackets, and geographical regions. Statistical analyses were performed using Python 3.12.0 to explore the relationships between these variables. <bold>Key Findings:</bold> AQI and NO<sub>2</sub> levels were significantly associated with increased incidences of COPD and tuberculosis, with rates rising especially during periods of heightened pollution. Conversely, ambient ozone exhibited inconsistent relationships with respiratory diseases, heavily influenced by socioeconomic factors. Higher GDP per capita and healthcare expenditure were linked to improved management of infectious diseases like tuberculosis, though they also corresponded with higher reporting of chronic conditions such as COPD. Tobacco smoking emerged as a critical risk factor for COPD across all regions. <bold>Conclusions:</bold> This study underscores the strong associations between air pollutants and respiratory diseases, particularly tuberculosis and COPD, with socioeconomic factors significantly influencing these relationships. Reducing air pollution and improving healthcare systems, particularly in low-income regions, are essential to mitigating the global burden of respiratory diseases.</p></abstract><kwd-group><kwd>air quality</kwd><kwd>respiratory disease</kwd><kwd>public health</kwd><kwd>nitrogen dioxide</kwd><kwd>pulmonary disease</kwd><kwd>asthma</kwd><kwd>tuberculosis</kwd></kwd-group><funding-group><funding-statement>This research received no external funding.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-tropicalmed-10-00056"><title>1. Introduction</title><p>Air pollution is a critical global health issue, contributing to an estimated 7 million premature deaths annually, with the majority resulting from respiratory and cardiovascular diseases [<xref rid="B1-tropicalmed-10-00056" ref-type="bibr">1</xref>]. This underscores the severe health consequences of prolonged exposure to harmful pollutants such as fine particulate matter (PM2.5), nitrogen dioxide (NO<sub>2</sub>), and ozone. Exposure to these pollutants can lead to or exacerbate respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD), and infectious diseases like tuberculosis. The Air Quality Index (AQI), a comprehensive metric encompassing multiple pollutants, has become a critical tool in assessing air quality and its associated health risks. Alongside AQI, specific measures of ambient ozone and NO<sub>2</sub> levels are increasingly employed in research to understand the complex dynamics between pollution exposure and respiratory disease incidence [<xref rid="B2-tropicalmed-10-00056" ref-type="bibr">2</xref>].</p><p>Extensive research has shown that air pollution significantly affects respiratory health, particularly chronic conditions such as asthma and COPD. Metrics like the Air Quality Index (AQI), ozone levels, and nitrogen dioxide (NO<sub>2</sub>) concentrations are widely used to study these relationships. For instance, higher AQI levels have been consistently associated with an increase in hospital visits and exacerbation of respiratory illnesses, especially in vulnerable groups such as children and the elderly [<xref rid="B2-tropicalmed-10-00056" ref-type="bibr">2</xref>]. Ambient ozone formed through chemical reactions between pollutants from vehicles and industrial emissions poses serious respiratory risks. Studies have shown how exposure to ozone worsens conditions such as asthma by inducing airway inflammation and oxidative stress [<xref rid="B3-tropicalmed-10-00056" ref-type="bibr">3</xref>,<xref rid="B4-tropicalmed-10-00056" ref-type="bibr">4</xref>]. Long-term exposure to high ozone levels has also been associated with a higher prevalence of COPD and other chronic respiratory disorders, particularly in regions with significant industrial pollution [<xref rid="B5-tropicalmed-10-00056" ref-type="bibr">5</xref>,<xref rid="B6-tropicalmed-10-00056" ref-type="bibr">6</xref>,<xref rid="B7-tropicalmed-10-00056" ref-type="bibr">7</xref>]. Similarly, nitrogen dioxide (NO<sub>2</sub>), which is primarily emitted from motor vehicles and industrial activities, is another pollutant of concern. Prolonged exposure to NO<sub>2</sub> has been shown to impair lung function, elevate the risk of respiratory infections, and accelerate the progression of diseases such as COPD [<xref rid="B8-tropicalmed-10-00056" ref-type="bibr">8</xref>,<xref rid="B9-tropicalmed-10-00056" ref-type="bibr">9</xref>]. Although the link between NO<sub>2</sub> and COPD is well established, its association with other diseases like asthma and tuberculosis remains underexplored, warranting further investigation.</p><p>The relationship between air pollution and respiratory diseases is further influenced by socioeconomic factors such as GDP per capita, smoking prevalence, and healthcare expenditure [<xref rid="B10-tropicalmed-10-00056" ref-type="bibr">10</xref>,<xref rid="B11-tropicalmed-10-00056" ref-type="bibr">11</xref>]. Higher-income countries with advanced healthcare systems may be better equipped to mitigate the health impacts of pollution through advanced medical care and public health interventions. Conversely, lower-income nations face the compounded challenges of high pollution levels and inadequate healthcare infrastructure, exacerbating the burden of respiratory diseases [<xref rid="B12-tropicalmed-10-00056" ref-type="bibr">12</xref>,<xref rid="B13-tropicalmed-10-00056" ref-type="bibr">13</xref>]. GDP per capita is often used as a proxy for a country&#x02019;s economic status and healthcare infrastructure, since wealthier nations have been observed to have lower rates of tuberculosis and other infectious diseases due to better access to healthcare and improved living conditions [<xref rid="B14-tropicalmed-10-00056" ref-type="bibr">14</xref>]. Asthma prevalence however remains high in high-income countries, suggesting that indoor pollution and lifestyle factors such as urbanization may play a more significant role [<xref rid="B15-tropicalmed-10-00056" ref-type="bibr">15</xref>,<xref rid="B16-tropicalmed-10-00056" ref-type="bibr">16</xref>].</p><p>Tobacco smoking is a well-established risk factor for respiratory diseases, particularly COPD and tuberculosis [<xref rid="B17-tropicalmed-10-00056" ref-type="bibr">17</xref>]. Smoking exacerbates the effects of air pollution by weakening the respiratory system, making individuals more susceptible to the harmful effects of pollutants like NO<sub>2</sub> and ozone [<xref rid="B18-tropicalmed-10-00056" ref-type="bibr">18</xref>]. Studies have shown that countries with high smoking prevalence and elevated pollution levels have a significantly higher incidence of respiratory diseases, stressing the need for comprehensive public health strategies that address both smoking cessation and pollution control [<xref rid="B19-tropicalmed-10-00056" ref-type="bibr">19</xref>,<xref rid="B20-tropicalmed-10-00056" ref-type="bibr">20</xref>]. Healthcare expenditure is another critical factor influencing the detection and management of respiratory diseases. Countries with higher healthcare spending tend to have more accurate diagnoses and better management of chronic conditions like asthma and COPD. In contrast, low-income countries with limited healthcare access face higher burdens of infectious diseases such as tuberculosis, particularly in regions with high pollution levels [<xref rid="B21-tropicalmed-10-00056" ref-type="bibr">21</xref>].</p><p>While existing studies have provided valuable insights into the relationships between air pollution and respiratory diseases, several gaps remain. Most studies have limited applicability because they focus on single pollutants or localized regions. Moreover, few studies have incorporated socioeconomic factors such as GDP, smoking rates, and healthcare expenditure into their analyses despite the clear influence these factors have on health outcomes. This research addresses these gaps by analyzing data from 27 countries over a four-year period, using a comprehensive approach that includes multiple pollutants and socioeconomic factors to give a more holistic exploration of the influence of air pollution on respiratory health. The insights gained aim to guide targeted public health initiatives designed to mitigate the global impact of respiratory diseases.</p><p>This study seeks to investigate the associations between AQI, ambient ozone levels, and NO<sub>2</sub> concentrations with the incidence of asthma, COPD, and tuberculosis across 27 countries over a four-year period (2018&#x02013;2021). Specifically, this research aims to answer the following questions:<list list-type="order"><list-item><p>What are the associations between the AQI, ambient ozone, and NO<sub>2</sub> concentrations, and the incidence rates of asthma, COPD, and tuberculosis?</p></list-item><list-item><p>How do socioeconomic factors such as GDP per capita, tobacco smoking prevalence, and healthcare expenditure influence these associations?</p></list-item><list-item><p>How do periods of high and low air pollution affect the incidence of respiratory diseases such as tuberculosis, COPD, and asthma?</p></list-item></list></p><p>The hypothesis of this study is that higher levels of air pollution, as measured by the Air Quality Index (AQI), ozone, and NO<sub>2</sub>, are associated with increased incidence rates of asthma, COPD, and tuberculosis, especially in countries with lower GDP per capita, higher smoking rates, and lower healthcare expenditure. Controlling for these socioeconomic factors will clarify how environmental and economic conditions interact to affect respiratory health. Additionally, it is hypothesized that there will be significant differences in disease incidence between high- and low-pollution periods, with higher rates of respiratory diseases, particularly tuberculosis and COPD, occurring during high-pollution periods.</p></sec><sec sec-type="methods" id="sec2-tropicalmed-10-00056"><title>2. Methodology</title><p>This section presents the study design which details the relationship between respiratory disease outcomes and air pollution across 27 countries over a four-year period (2018&#x02013;2021). Sources of data, statistical analysis, ethical considerations, and potential bias in data sources are also presented in this section.</p><sec id="sec2dot1-tropicalmed-10-00056"><title>2.1. Study Design</title><p>This study utilized a cross-sectional design to investigate the relationship between air pollution and respiratory disease outcomes across 27 countries (<xref rid="app1-tropicalmed-10-00056" ref-type="app">Appendix A</xref>) over four years (2018&#x02013;2021). Although data were collected over a four-year period, the analysis was conducted at a single point in time by using average values over the study period. This approach ensures that the study remains cross-sectional, as it examines associations between air pollution and respiratory health without assessing temporal trends.</p><p>This design allowed for the analysis of multiple variables simultaneously, providing a comprehensive view of both global trends and country-specific variations. The 27 countries included in this study were carefully selected to ensure geographic diversity, variation in pollution levels, and socioeconomic representation. To achieve this, we chose six countries from each major continent (Asia, Africa, Europe, North America, and South America) and two from Australia, capturing a broad spectrum of air pollution exposure, income brackets, and healthcare infrastructures. This approach allowed us to explore how the relationships between air pollution and respiratory diseases differ across regions with distinct environmental and economic conditions.</p><p>Countries with incomplete or inconsistent data on key variables were excluded to maintain the integrity and comparability of our analysis. By ensuring that only countries with reliable data were included, we strengthened the validity of our findings while preserving the study&#x02019;s global perspective. Including a mix of high-income and low-income countries ensures the study captured diverse settings, shedding light on how economic and environmental disparities impact health outcomes.</p></sec><sec id="sec2dot2-tropicalmed-10-00056"><title>2.2. Variable Selection</title><p>The Air Quality Index (AQI), ozone, and nitrogen dioxide (NO<sub>2</sub>) were selected as primary air pollution indicators due to their well-established roles in influencing respiratory health [<xref rid="B22-tropicalmed-10-00056" ref-type="bibr">22</xref>,<xref rid="B23-tropicalmed-10-00056" ref-type="bibr">23</xref>,<xref rid="B24-tropicalmed-10-00056" ref-type="bibr">24</xref>]. The AQI is a composite measure that reflects overall air quality, including concentrations of various pollutants like particulate matter (PM2.5), carbon monoxide, and sulfur dioxide, making it a comprehensive indicator of general air pollution levels. Ozone and NO<sub>2</sub>, on the other hand, are two key pollutants that have been extensively studied for their direct effects on lung function and respiratory diseases [<xref rid="B3-tropicalmed-10-00056" ref-type="bibr">3</xref>,<xref rid="B5-tropicalmed-10-00056" ref-type="bibr">5</xref>,<xref rid="B25-tropicalmed-10-00056" ref-type="bibr">25</xref>,<xref rid="B26-tropicalmed-10-00056" ref-type="bibr">26</xref>,<xref rid="B27-tropicalmed-10-00056" ref-type="bibr">27</xref>]. Ozone, a reactive gas formed by the interaction of sunlight with pollutants, is known to cause airway inflammation, while NO<sub>2</sub>, primarily generated from vehicular and industrial emissions, is a well-documented contributor to chronic respiratory conditions such as asthma and COPD [<xref rid="B27-tropicalmed-10-00056" ref-type="bibr">27</xref>]. By including these variables, this study aimed to capture a broad spectrum of air pollution&#x02019;s impact on respiratory health, as well as the differential effects of individual pollutants. The AQI is calculated using the following equation:<disp-formula id="FD1-tropicalmed-10-00056"><mml:math id="mm1" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mrow><mml:mi>AQI</mml:mi><mml:mo>=</mml:mo><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>h</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msub><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>w</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>h</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msub><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>w</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mfrac></mml:mstyle></mml:mrow><mml:mrow><mml:mo>&#x000d7;</mml:mo><mml:mo>(</mml:mo><mml:mi>C</mml:mi><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>w</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>w</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mrow></mml:math></disp-formula>
where <inline-formula><mml:math id="mm2" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula> = observed concentration of the pollutant.</p><p><inline-formula><mml:math id="mm3" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>w</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> = lower bound of the AQI category for the given pollutant concentration.</p><p><inline-formula><mml:math id="mm4" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>h</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> = upper bound of the AQI category for the given pollutant concentration.</p><p><inline-formula><mml:math id="mm5" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>w</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> = lower bound of the AQI range for the pollutant category.</p><p><inline-formula><mml:math id="mm6" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>h</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> = upper bound of the AQI range for the pollutant category.</p><p>In addition to air pollution variables, socioeconomic factors were included to account for their potential confounding effects and to explore how they may modify the relationship between air pollution and respiratory disease. Tobacco use is a well-known risk factor for respiratory diseases [<xref rid="B19-tropicalmed-10-00056" ref-type="bibr">19</xref>,<xref rid="B28-tropicalmed-10-00056" ref-type="bibr">28</xref>], particularly COPD [<xref rid="B17-tropicalmed-10-00056" ref-type="bibr">17</xref>], and its prevalence can act as an important confounder in studies examining air pollution and respiratory outcomes. As smoking is a major cause of lung damage, the study controlled for this factor to isolate the independent effects of air pollution. Similarly, GDP per capita and healthcare expenditure were included as proxies for a country&#x02019;s level of economic development and healthcare infrastructure. Higher GDP often correlates with better healthcare access [<xref rid="B29-tropicalmed-10-00056" ref-type="bibr">29</xref>], advanced medical technologies, and improved public health policies, which can influence the detection, management, and outcomes of respiratory diseases. Conversely, healthcare expenditure can directly affect the quality and availability of health services, such as respiratory disease treatments and air quality-monitoring programs. Both of these variables are crucial in understanding the broader social and economic context in which air pollution affects public health, as they may influence not only disease prevalence but also the capacity of nations to address and mitigate the health impacts of air pollution.</p></sec><sec id="sec2dot3-tropicalmed-10-00056"><title>2.3. Source of Data</title><p>To ensure the accuracy and credibility of this study, data were obtained exclusively from reputable databases to ensure accuracy and credibility.</p><list list-type="order"><list-item><p>Air Pollution Data: AQI values were obtained from the IQAir World Air Quality (<uri xlink:href="https://www.iqair.com/world-most-polluted-countries">https://www.iqair.com/world-most-polluted-countries</uri> (accessed on 20 October 2024)) which compiles pollution data from governments and independent monitoring stations globally. Since this study used secondary AQI data, AQI value was not directly calculated but relied on the estimates provided by IQAir. These values are derived from ground-based air quality-monitoring stations, satellite observations, and machine learning models that integrate meteorological data to improve accuracy in areas with limited ground monitoring. While we do not have access to IQAir&#x02019;s proprietary equations, their data are consistent with international AQI calculation standards, making them a reliable source for this study (<uri xlink:href="https://www.iqair.com/ca/newsroom/airvisual_vs_nowcast?srsltid=AfmBOop4_mw1JwaOz-dkunr_PeMF2zJ8igqOd2D--jAFSoSR3nbN6Odq">https://www.iqair.com/ca/newsroom/airvisual_vs_nowcast?srsltid=AfmBOop4_mw1JwaOz-dkunr_PeMF2zJ8igqOd2D--jAFSoSR3nbN6Odq</uri> (accessed on 20 October 2024)). Ambient ozone and NO<sub>2</sub> levels were sourced from the Global Burden of Disease GBD Results Tool (<uri xlink:href="https://vizhub.healthdata.org/gbd-results/#">https://vizhub.healthdata.org/gbd-results/#</uri> (accessed on 20 October 2024)), which provides population-weighted averages, accounting for pollutant exposure across diverse demographics.</p></list-item><list-item><p>Health Data: The incidence rates for asthma, COPD, and tuberculosis were obtained from the GBD Results Tool (<uri xlink:href="https://vizhub.healthdata.org/gbd-results/#">https://vizhub.healthdata.org/gbd-results/#</uri> (accessed on 20 October 2024)). These rates were standardized across countries, covering all age groups and sexes.</p></list-item><list-item><p>Socioeconomic Indicators: Data on GDP per capita and tobacco smoking prevalence were retrieved from the World Bank Database (<uri xlink:href="https://databank.worldbank.org/source/world-development-indicators">https://databank.worldbank.org/source/world-development-indicators</uri> (accessed on 20 October 2024)) while healthcare expenditure statistics were sourced from the WHO Global Health Expenditure Database (<uri xlink:href="https://www.who.int/data/gho/data/indicators/indicator-details/GHO/current-health-expenditure-(che)-per-capita-in-us-dollar">https://www.who.int/data/gho/data/indicators/indicator-details/GHO/current-health-expenditure-(che)-per-capita-in-us-dollar</uri> (accessed on 20 October 2024)). These indicators provided essential context for controlling confounding effects on health outcomes.</p></list-item></list><p>Countries were selected based on data availability and completeness, ensuring the inclusion of a diverse range of pollution levels, income brackets, and healthcare infrastructures. The inclusion criteria ensured that the findings could be generalized to various global contexts.</p></sec><sec id="sec2dot4-tropicalmed-10-00056"><title>2.4. Statistical Analysis</title><p>All statistical analyses were conducted using Python 3.12.0. Libraries such as pandas for data manipulation, statsmodels for multivariate regression analysis, and scipy for Pearson correlation analysis were used. The level of significance was defined as <italic toggle="yes">p</italic>-value &#x02264; 0.05. The analysis involved exploring the relationships between air pollution indicators (AQI, ozone, NO<sub>2</sub>) and disease incidences (asthma, COPD, tuberculosis) while adjusting for potential confounders (GDP per capita, tobacco use, and health expenditure). Visualizations were generated using matplotlib 3.7.0 to present regression results and statistical associations.</p><p>Standard multivariate linear regression models were used to assess the impact of each air pollution marker (AQI, ozone, NO<sub>2</sub>) on the incidence of asthma, COPD, and tuberculosis. Each model was adjusted for the confounders (GDP per capita, tobacco use, health expenditure) to isolate the independent effect of air pollution on respiratory health outcomes. All predictor variables (air pollution markers and confounders) were entered into the model simultaneously. Variance Inflation Factor analysis confirmed no significant multicollinearity.</p><p>The following general model structure was applied for each disease outcome:<disp-formula>Disease Incidence<italic toggle="yes"><sub>i</sub></italic> = &#x003b2;<sub>0</sub> + &#x003b2;<sub>1</sub>AQI<italic toggle="yes"><sub>i</sub></italic> + &#x003b2;<sub>2</sub>O3<italic toggle="yes"><sub>i</sub></italic> + &#x003b2;<sub>3</sub>NO2<italic toggle="yes"><sub>i</sub></italic> + &#x003b2;<sub>4</sub>GDP<italic toggle="yes"><sub>i</sub></italic> + &#x003b2;<sub>5</sub>Tobacco Use<italic toggle="yes"><sub>i</sub></italic> + &#x003b2;<sub>6</sub>Health Expenditure<italic toggle="yes"><sub>i</sub></italic> + &#x003f5;<italic toggle="yes"><sub>i</sub></italic></disp-formula></p><list list-type="bullet"><list-item><p>&#x003b2;<sub>1</sub>, &#x003b2;<sub>2</sub>, and &#x003b2;<sub>3</sub> represent the coefficients for air pollution markers.</p></list-item><list-item><p>&#x003b2;<sub>4</sub>, &#x003b2;<sub>5</sub>, and &#x003b2;<sub>6</sub> represent the coefficients for confounders.</p></list-item><list-item><p><italic toggle="yes"><sub>i</sub></italic> represents each country.</p></list-item></list><p>One-way ANOVA tests were conducted to determine whether respiratory disease incidence rates differed significantly between high- and low-pollution periods. Countries were stratified into high- and low-pollution groups based on the median air pollution markers of AQI, ozone and NO<sub>2</sub>, and the differences in asthma, COPD, and tuberculosis rates between these periods were tested for statistical significance.</p></sec><sec id="sec2dot5-tropicalmed-10-00056"><title>2.5. Ethical Considerations</title><p>This study utilized publicly accessible data and no human subjects. There were no ethical concerns related to the use of human subjects. All datasets were de-identified and reported at the national level to ensure the absence of personal or sensitive information. The study complied fully with ethical standards for secondary data usage without requiring formal ethical approval as there was no direct interaction with individuals.</p></sec><sec id="sec2dot6-tropicalmed-10-00056"><title>2.6. Potential Bias in Data Sources</title><p>The data for this study were obtained from reputable and globally recognized databases. However, it is essential to consider the potential for biases arising from differences in how countries report air pollution and health statistics. Variations in air quality-monitoring systems, accuracy of measurements, and frequency of data collection may lead to inconsistencies in the reported levels of AQI, ozone, and nitrogen dioxide. Similarly, health reporting systems differ in reliability, and underreporting of respiratory diseases is more common in countries with limited healthcare infrastructure. Such disparities may impact the findings and limit their generalizability. In addition to the known biases, it is possible that other unaccounted factors, such as differences in environmental policies, urbanization levels, and access to healthcare, could further influence the observed relationships between pollution and respiratory health outcomes. These challenges highlight the need for careful interpretation of cross-country comparisons, as differences in data quality could influence the observed relationships between pollution and respiratory health. Future research should aim to resolve these discrepancies by obtaining more detailed and standardized data across regions. <xref rid="tropicalmed-10-00056-f001" ref-type="fig">Figure 1</xref> summarizes and presents the entire research methodology in a flowchart.</p></sec></sec><sec sec-type="results" id="sec3-tropicalmed-10-00056"><title>3. Results</title><p>This section presents a statistical summary of the dataset. Correlation analysis, multivariate regression, and limitations of the study are presented in this section.</p><sec id="sec3dot1-tropicalmed-10-00056"><title>3.1. Summary Statistics</title><p><xref rid="tropicalmed-10-00056-t001" ref-type="table">Table 1</xref> below provides the descriptive statistics of the key variables. Measures of central tendency (mean, median) and dispersion (standard deviation, interquartile range) were used to summarize the data. AQI values vary widely (5&#x02013;97, mean = 21.68, Std Dev = 19.09), reflecting differences in pollution exposure, while ozone and NO<sub>2</sub> concentrations also show significant variability (max = 49.16 ppb and 35.33 ppb, respectively). Asthma has the highest mean prevalence (558.40 per 100k), followed by COPD (225.99 per 100k) and tuberculosis (79.82 per 100k), with TB showing high variability (Std Dev = 112.93, max = 452.63 per 100k). Socioeconomic disparities are evident, with GDP per capita ranging from USD 758.30 to USD 71,056.00 and healthcare expenditure from USD 23.85 to USD 12,051.10, suggesting that economic inequality may influence how countries manage respiratory diseases and pollution exposure.</p></sec><sec id="sec3dot2-tropicalmed-10-00056"><title>3.2. Correlation Analysis</title><sec id="sec3dot2dot1-tropicalmed-10-00056"><title>3.2.1. Across All Countries</title><p><xref rid="tropicalmed-10-00056-t002" ref-type="table">Table 2</xref> displays the outcomes of the Pearson correlation study about the relationship between pollutants and the incidence of respiratory diseases across the sample countries. The relationship between AQI and respiratory diseases showed significant negative correlations with both asthma (r = &#x02212;0.320, <italic toggle="yes">p</italic> &#x0003c; 0.001) and COPD (r = &#x02212;0.340, <italic toggle="yes">p</italic> &#x0003c; 0.001), while a significant positive association was observed with tuberculosis incidence (r = 0.377, <italic toggle="yes">p</italic> &#x0003c; 0.001). Similarly, ozone levels negatively correlated with asthma (r = &#x02212;0.257, <italic toggle="yes">p</italic> = 0.007) and COPD (r = &#x02212;0.269, <italic toggle="yes">p</italic> = 0.005) while showing a strong positive association with tuberculosis (r = 0.377, <italic toggle="yes">p</italic> &#x0003c; 0.001). NO<sub>2</sub> followed a different pattern, with significant negative correlations with asthma (r = &#x02212;0.265, <italic toggle="yes">p</italic> = 0.005) and COPD (r = &#x02212;0.323, <italic toggle="yes">p</italic> &#x0003c; 0.001), and a strong negative association with tuberculosis (r = &#x02212;0.404, <italic toggle="yes">p</italic> &#x0003c; 0.001). These findings suggest differential effects of pollutants on chronic versus infectious respiratory diseases, possibly influenced by regional pollution control policies, immune response mechanisms, and socioeconomic conditions.</p><p><xref rid="tropicalmed-10-00056-f002" ref-type="fig">Figure 2</xref> depicts the scatter plots that reveal the relationships between the AQI, ozone, and NO<sub>2</sub> levels and respiratory diseases (asthma, COPD, and tuberculosis). The scatter plots suggest distinct patterns for each disease. Asthma cases are widely distributed across pollutant levels, indicating multiple influencing factors beyond air pollution. Tuberculosis cases, on the other hand, show a concentration at lower pollutant levels and a weaker correlation with air quality indicators, reflecting their infectious nature rather than being predominantly pollution-driven.</p><p>In contrast, COPD exhibits a clearer trend across pollutants, particularly ozone and NO<sub>2</sub>, with higher pollutant levels correlating with increased COPD cases. This aligns with known biological mechanisms where these pollutants exacerbate airway inflammation and chronic respiratory damage. The scatter plots for COPD are less dispersed compared to those for asthma, suggesting that pollution may have a more direct impact on COPD than on asthma. Tuberculosis remains relatively unaffected by pollutant variations, reflecting its primary dependence on infectious and socioeconomic factors rather than environmental pollutants.</p><p>The scatter plots indicate that air pollutants like ozone and NO<sub>2</sub> are more strongly associated with COPD than asthma or tuberculosis. Asthma appears to be influenced by a broader range of factors, while tuberculosis shows minimal correlation with pollution. These observations highlight the need for targeted strategies in managing respiratory diseases based on their distinct environmental and biological drivers.</p></sec><sec id="sec3dot2dot2-tropicalmed-10-00056"><title>3.2.2. Country-by-Country Correlation</title><p><xref rid="tropicalmed-10-00056-t003" ref-type="table">Table 3</xref> presents the results of the country-specific Pearson correlation analysis, showing the significant relationships between air pollution markers&#x02014;AQI, ozone, and NO<sub>2</sub>&#x02014;and the incidence of asthma, COPD, and tuberculosis. The findings reveal distinct trends across different pollutants and diseases. While some trends align with broader expectations, others suggest unique regional influences that shape these relationships.</p><p>A positive correlation between AQI and tuberculosis was found in several countries, such as Japan (r = 0.986, <italic toggle="yes">p</italic> = 0.014) and South Africa (r = 0.850, <italic toggle="yes">p</italic> = 0.038), indicating that higher AQI levels are associated with increased tuberculosis incidence. This could be due to urban crowding and prolonged exposure to fine particulate matter, which has been linked to weakened immune function. In contrast, India, despite its high pollution levels, did not exhibit a similar trend. This discrepancy may stem from differences in TB surveillance, healthcare accessibility, and the prevalence of other risk factors such as malnutrition or HIV co-infections.</p><p>Asthma correlations also varied significantly. In Costa Rica (r = 0.986, <italic toggle="yes">p</italic> = 0.014) and Portugal (r = 0.995, <italic toggle="yes">p</italic> = 0.004), the AQI was positively associated with asthma, aligning with the expectation that pollution exacerbates airway hypersensitivity. However, in Chile (r = &#x02212;0.958, <italic toggle="yes">p</italic> = 0.042) and South Africa (r = &#x02212;0.956, <italic toggle="yes">p</italic> = 0.044), ozone had a negative correlation with asthma, suggesting that climatic or seasonal variations may influence asthma triggers differently across regions.</p><p>The relationship between AQI and COPD varied across countries. Thailand showed a negative correlation (r = &#x02212;0.990, <italic toggle="yes">p</italic> = 0.010), suggesting that as AQI levels decreased, COPD incidence also dropped. Conversely, in other countries like India, no significant relationship was detected, emphasizing regional differences in disease dynamics.</p><p>Ozone was significantly associated with COPD in multiple countries. For instance, Poland (r = 0.978, <italic toggle="yes">p</italic> = 0.022), India (r = 0.765, <italic toggle="yes">p</italic> = 0.023), and Thailand (r = 0.956, <italic toggle="yes">p</italic> = 0.044) all demonstrated a positive correlation between ozone and COPD incidence, suggesting that higher ozone levels were linked to an increase in COPD cases. However, in countries like the United States (r = &#x02212;0.99, r = 0.00041), Portugal (r = &#x02212;0.9902, <italic toggle="yes">p</italic> = 0.0098), Sweden (r = &#x02212;0.961, <italic toggle="yes">p</italic> = 0.039) and Macedonia (r = &#x02212;0.998, <italic toggle="yes">p</italic> = 0.001), ozone exhibited a negative correlation with COPD, an unexpected finding that may reflect regional differences in emission sources, healthcare interventions, or variations in population susceptibility.</p><p>A contrasting pattern emerged in Brazil. While AQI correlated positively with tuberculosis (r = 0.982, <italic toggle="yes">p</italic> = 0.018), ozone had a strong negative correlation with TB (r = &#x02212;0.999, <italic toggle="yes">p</italic> &#x0003c; 0.001). This suggests that certain pollutants may exacerbate TB transmission, while others could play a role in reducing bacterial survival or altering transmission dynamics. A similar negative correlation between ozone and TB was found in Colombia (r = &#x02212;0.999, <italic toggle="yes">p</italic> = 0.0003), Pakistan (r = &#x02212;0.993, <italic toggle="yes">p</italic> = 0.007), and Nigeria (r = &#x02212;0.998, <italic toggle="yes">p</italic> = 0.0016), possibly due to interactions between air quality policies and disease control efforts.</p><p>For tuberculosis, a negative correlation with ozone was observed in Poland (r = &#x02212;0.987, <italic toggle="yes">p</italic> = 0.013) and India (r = &#x02212;0.703, <italic toggle="yes">p</italic> = 0.045), indicating that higher ozone levels were associated with a decrease in tuberculosis incidence.</p><p>The relationship between NO<sub>2</sub> and COPD was consistently positive across several countries. Poland showed a strong positive correlation (r = 0.973, <italic toggle="yes">p</italic> = 0.027), as did South Africa (r = 0.823, <italic toggle="yes">p</italic> = 0.045). These results indicate that higher NO<sub>2</sub> levels are significantly associated with increased COPD incidence in these countries. A similar trend was found for tuberculosis in South Africa (r = 0.850, <italic toggle="yes">p</italic> = 0.038), where higher NO<sub>2</sub> levels corresponded with greater tuberculosis incidence. In Pakistan (r = &#x02212;0.954, <italic toggle="yes">p</italic> = 0.046), however, NO<sub>2</sub> was negatively associated with COPD, which contradicts studies that commonly link nitrogen dioxide to lung inflammation and disease progression. This may indicate strict NO<sub>2</sub> regulations or reduced exposure in areas with high COPD prevalence, warranting further investigation.</p></sec></sec><sec id="sec3dot3-tropicalmed-10-00056"><title>3.3. Socioeconomic Factors</title><sec id="sec3dot3dot1-tropicalmed-10-00056"><title>3.3.1. Across All Countries</title><p>The socioeconomic variables that were considered as potential covariates for disease incidence across all countries are summarized in <xref rid="tropicalmed-10-00056-t004" ref-type="table">Table 4</xref> below. Pearson correlation analysis results revealed significant relationships between socioeconomic confounders and respiratory disease incidence. GDP per capita showed a strong positive association with COPD (r = 0.77, <italic toggle="yes">p</italic> &#x0003c; 0.001), indicating that wealthier countries report higher COPD rates, likely due to better diagnostic capabilities. Conversely, GDP was negatively associated with tuberculosis (r = &#x02212;0.55, <italic toggle="yes">p</italic> &#x0003c; 0.001), suggesting that wealthier countries have lower rates of tuberculosis, likely due to better healthcare infrastructure. No significant correlation was found between GDP and asthma (r = 0.18, <italic toggle="yes">p</italic> = 0.12).</p><p>Tobacco use was negatively correlated with asthma incidence (r = &#x02212;0.29, <italic toggle="yes">p</italic> = 0.01) but positively associated with COPD (r = 0.31, <italic toggle="yes">p</italic> = 0.005), highlighting smoking as a key risk factor for the disease. No significant correlation was found between tobacco use and tuberculosis (r = 0.01, <italic toggle="yes">p</italic> = 0.95).</p><p>Health expenditure was significantly correlated with both asthma (r = 0.26, <italic toggle="yes">p</italic> = 0.02) and COPD (r = 0.74, <italic toggle="yes">p</italic> &#x0003c; 0.001), suggesting that better healthcare systems are associated with increased detection and reporting of these diseases. It was negatively correlated with tuberculosis (r = &#x02212;0.48, <italic toggle="yes">p</italic> &#x0003c; 0.001), indicating that higher health spending is linked to lower tuberculosis incidence.</p><p>In summary, higher GDP and health expenditure are associated with better outcomes for chronic diseases like COPD and lower tuberculosis rates, while tobacco use remains a significant factor for COPD. These findings highlight the importance of socioeconomic factors in shaping respiratory disease prevalence.</p></sec><sec id="sec3dot3dot2-tropicalmed-10-00056"><title>3.3.2. Country by Country</title><p>The Pearson correlation analysis of socioeconomic factors and respiratory disease incidence revealed several significant country-specific relationships as shown in <xref rid="tropicalmed-10-00056-t005" ref-type="table">Table 5</xref>. GDP per capita demonstrated diverse associations with COPD. In countries like Turkey (r = &#x02212;0.99, <italic toggle="yes">p</italic> = 0.04), Angola (r = &#x02212;0.99, <italic toggle="yes">p</italic> = 0.007), and Chile (r = &#x02212;0.99, <italic toggle="yes">p</italic> = 0.05), GDP per capita showed a negative correlation with COPD incidence, suggesting that wealthier nations may have better healthcare infrastructure, which could mitigate COPD risks. However, Ethiopia exhibited a positive correlation (r = 0.99, <italic toggle="yes">p</italic> = 0.01), implying that higher GDP in this country might coincide with more frequent diagnosis and reporting of COPD, possibly due to improved diagnostic capabilities and healthcare access.</p><p>When examining tuberculosis, the relationship with GDP per capita was more varied. A positive correlation was found in Australia (r = 0.99, <italic toggle="yes">p</italic> = 0.02), which could reflect ongoing challenges in controlling tuberculosis despite the country&#x02019;s wealth. Conversely, in New Zealand and Bangladesh, a negative correlation was observed (r = &#x02212;0.99, <italic toggle="yes">p</italic>-values of 0.001 and 0.05, respectively), suggesting that higher GDP in these countries may be linked with better tuberculosis control measures and lower incidence rates.</p><p>Tobacco consumption also had distinct effects on asthma incidence. In Australia (r = 0.99, <italic toggle="yes">p</italic> = 0.04) and New Zealand (r = 0.99, <italic toggle="yes">p</italic> = 0.03), tobacco use was positively correlated with asthma), indicating that higher tobacco consumption may exacerbate asthma cases in these nations. On the other hand, Poland (r = &#x02212;0.99, <italic toggle="yes">p</italic> = 0.003) and Sweden (r = &#x02212;0.99, <italic toggle="yes">p</italic> = 0.009) showed negative correlations, which could point to differences in smoking patterns, national health policies, or diagnostic practices that may reduce the impact of tobacco on asthma in these countries.</p><p>Health expenditure was positively correlated with COPD incidence in several countries, including India (r = 0.99, <italic toggle="yes">p</italic> = 0.01), Ethiopia (r = 0.99, <italic toggle="yes">p</italic> = 0.03), Thailand (r = 0.99, <italic toggle="yes">p</italic> = 0.04), and Bangladesh (r = 0.99, <italic toggle="yes">p</italic> = 0.04). This suggests that higher health expenditure is associated with increased detection and reporting of COPD cases, potentially due to enhanced healthcare services and infrastructure. Conversely, in Bangladesh, health expenditure showed a negative correlation with tuberculosis (r = &#x02212;0.99, <italic toggle="yes">p</italic> = 0.02), which may indicate that increased spending on healthcare programs is more effective in reducing tuberculosis incidence in this country.</p><p>These findings emphasize the complex and context-specific role of socioeconomic factors in the incidence of respiratory diseases across different countries. While higher GDP and health expenditure appear to improve the management of chronic conditions like COPD, they may not always correlate with reduced incidence of diseases like tuberculosis, highlighting the need for tailored healthcare strategies. Additionally, the relationship between tobacco use and asthma underscores the importance of effective public health policies to curb smoking rates, especially in countries with higher tobacco consumption.</p></sec></sec><sec id="sec3dot4-tropicalmed-10-00056"><title>3.4. Multivariate Regression Analysis</title><p>The result of the multivariate regression analysis in <xref rid="tropicalmed-10-00056-t006" ref-type="table">Table 6</xref> examined the associations between air pollution markers (AQI, ozone, and NO<sub>2</sub>) and the incidence of asthma, COPD, and tuberculosis, while controlling for significant covariates such as GDP per capita, smoking prevalence, and healthcare expenditure.</p><p>For asthma, the analysis revealed no significant associations with any of the pollutants. AQI showed a negative relationship with asthma (&#x003b2; = &#x02212;4.33, <italic toggle="yes">p</italic> = 0.56), but this was not statistically significant. Similarly, ozone (&#x003b2; = 2.997, <italic toggle="yes">p</italic> = 0.552) and NO<sub>2</sub> (&#x003b2; = 3.937, <italic toggle="yes">p</italic> = 0.211) exhibited positive but non-significant associations with asthma incidence.</p><p>In the case of COPD, the findings were more telling. AQI demonstrated a significant negative correlation with COPD (&#x003b2; = &#x02212;7.34, <italic toggle="yes">p</italic> = 0.0087), suggesting that higher AQI levels are associated with an increase in COPD prevalence. This relationship is noteworthy as it highlights the impact of poor air quality on respiratory health. However, ozone (&#x003b2; = 2.05, <italic toggle="yes">p</italic> = 0.258) and NO<sub>2</sub> (&#x003b2; = 1.26, <italic toggle="yes">p</italic> = 0.254) did not show significant associations with COPD incidence.</p><p>For tuberculosis, NO<sub>2</sub> displayed a significant negative association with disease incidence (&#x003b2; = &#x02212;5.10, <italic toggle="yes">p</italic> &#x0003c; 0.001), indicating that higher NO<sub>2</sub> levels are linked to a lower incidence of tuberculosis. This finding is unexpected and warrants further investigation to explore the mechanisms behind this relationship. Ozone approached significance (&#x003b2; = 4.31, <italic toggle="yes">p</italic> = 0.0673), suggesting a potential positive link with tuberculosis incidence, but the result was not statistically significant. AQI, however, did not show a significant association with tuberculosis (&#x003b2; = 0.29, <italic toggle="yes">p</italic> = 0.907).</p><p>These results underscore the differential effects that various air pollutants have on respiratory diseases. AQI was significantly associated with COPD, indicating that poor air quality contributes to the prevalence of chronic respiratory conditions. Conversely, NO<sub>2</sub> was negatively correlated with tuberculosis incidence, suggesting that higher levels of this pollutant might be associated with lower tuberculosis rates, though the underlying reasons for this remain unclear. The findings also highlight the importance of controlling for relevant covariates, such as socioeconomic factors and healthcare expenditure, to accurately assess the impacts of air pollution on respiratory diseases.</p><p><xref rid="tropicalmed-10-00056-f003" ref-type="fig">Figure 3</xref> displays the scatter plots showing the relationships between three air pollutants (AQI, ozone, and NO<sub>2</sub>) and the incidence rates of three respiratory diseases (asthma, COPD, and tuberculosis). The scatter plot for asthma (<xref rid="tropicalmed-10-00056-f003" ref-type="fig">Figure 3</xref>a) shows a broad distribution of cases across all pollutant levels. While there is no clear linear trend, some clustering occurs at moderate levels of ozone and NO<sub>2</sub> (10&#x02013;25), suggesting that pollutants may contribute to asthma but are not the sole determinants. Asthma incidence is influenced by a combination of environmental, genetic, and allergen exposure factors, which could explain the variability seen in the plot.</p><p><xref rid="tropicalmed-10-00056-f003" ref-type="fig">Figure 3</xref>b highlights COPD incidence against air pollutants. Unlike asthma, COPD shows a more defined positive correlation with ozone and NO<sub>2</sub> levels, particularly at higher concentrations. This trend aligns with the established role of these pollutants in inducing chronic inflammation and airway damage, which are hallmark features of COPD pathophysiology. The relationship with AQI appears less pronounced, potentially because AQI is a composite measure, diluting the impact of specific pollutants like NO<sub>2</sub> and ozone on COPD.</p><p>In <xref rid="tropicalmed-10-00056-f003" ref-type="fig">Figure 3</xref>c, tuberculosis incidence remains low and scattered across pollutant levels, with no obvious pattern. This is consistent with tuberculosis being an infectious disease driven by factors like socioeconomic conditions and immune status, rather than direct environmental pollutants. While pollutants may indirectly weaken lung defenses, their role in driving tuberculosis is minimal compared to infections. Overall, these graphs highlight stronger associations between pollution and COPD, moderate links to asthma, and negligible influence on tuberculosis.</p></sec><sec id="sec3dot5-tropicalmed-10-00056"><title>3.5. ANOVA Analysis</title><p><xref rid="tropicalmed-10-00056-t007" ref-type="table">Table 7</xref> shows the one-way ANOVA analysis; the analysis examined the variance in asthma, COPD, and tuberculosis incidence between high- and low-pollution periods, across all countries, for three key pollutants: AQI, ozone, and NO<sub>2</sub>.</p><p>For asthma, none of the pollution levels showed statistically significant variance. AQI levels (F = 1.45, <italic toggle="yes">p</italic> = 0.23), ozone levels (F = 0.001, <italic toggle="yes">p</italic> = 0.98), and NO<sub>2</sub> levels (F = 1.92, <italic toggle="yes">p</italic> = 0.17) were not significantly associated with differences in asthma incidence between high- and low-pollution periods.</p><p>In contrast, COPD incidence showed significant variance with AQI (F = 42.84, <italic toggle="yes">p</italic> &#x0003c; 0.001) and NO<sub>2</sub> levels (F = 15.32, <italic toggle="yes">p</italic> &#x0003c; 0.001), indicating that periods of high pollution were strongly associated with increased COPD rates. However, ozone levels did not significantly affect COPD incidence (F = 2.95, <italic toggle="yes">p</italic> = 0.09).</p><p>For tuberculosis, all three pollutants were significantly associated with differences in disease incidence between high- and low-pollution periods. AQI (F = 38.35, <italic toggle="yes">p</italic> &#x0003c; 0.001), NO<sub>2</sub> (F = 20.09, <italic toggle="yes">p</italic> &#x0003c; 0.001), and ozone (F = 5.27, <italic toggle="yes">p</italic> = 0.02) all showed significant variance, suggesting that higher-pollution periods corresponded with increased tuberculosis incidence.</p><p>These findings demonstrate that while asthma incidence was not significantly affected by pollution levels, both COPD and tuberculosis showed strong associations with high-pollution periods, particularly for AQI and NO<sub>2</sub>. These findings highlight that while asthma incidence was not significantly affected by pollution levels, both COPD and tuberculosis showed strong associations with high-pollution periods, particularly for AQI and NO<sub>2</sub>.</p><p><xref rid="tropicalmed-10-00056-f004" ref-type="fig">Figure 4</xref> shows box plots that compare the incidence rates of asthma, COPD, and tuberculosis across high and low levels of air pollutants (AQI, ozone, and NO<sub>2</sub>). For asthma (<xref rid="tropicalmed-10-00056-f004" ref-type="fig">Figure 4</xref>a), the data indicate minimal differences between high and low pollutant levels for AQI, ozone, and NO<sub>2</sub>. While the median values of asthma incidence are slightly elevated in the high-pollutant categories, the large interquartile ranges and overlapping whiskers suggest weak or inconsistent associations. This finding aligns with the multifactorial nature of asthma, where genetic predispositions, allergens, and environmental triggers collectively influence disease risk.</p><p><xref rid="tropicalmed-10-00056-f004" ref-type="fig">Figure 4</xref>b shows the box plots for COPD, which reveal more distinct differences between high- and low-pollutant categories. High AQI levels appear to correlate with lower COPD incidence, an unexpected finding possibly reflecting confounding factors like the composite nature of AQI or differing exposure sources. However, for ozone and NO<sub>2</sub>, the data indicate that high pollutant levels are associated with higher COPD incidence, as evidenced by elevated medians and wider distributions. This supports established research linking these pollutants to chronic airway inflammation and damage, which are key processes in COPD pathogenesis.</p><p><xref rid="tropicalmed-10-00056-f004" ref-type="fig">Figure 4</xref>c depicts tuberculosis incidence, which is consistently higher in high-pollutant categories for AQI, ozone, and NO<sub>2</sub>. Notably, while the median tuberculosis incidence remains low, the presence of outliers in the high-pollutant groups suggests that specific populations or regions with high exposure may experience greater vulnerability. This trend could reflect the indirect role of pollutants in weakening lung defenses, thus increasing susceptibility to infections. Overall, the data indicate strong pollutant links with COPD, potential outlier-driven associations with tuberculosis, and weaker relationships for asthma.</p></sec><sec id="sec3dot6-tropicalmed-10-00056"><title>3.6. Discussion</title><p>This study explored the complex associations between air pollution and respiratory disease incidence across 27 countries, while also examining country-specific variations. This research highlights the crucial influence of environmental factors, as well as socioeconomic conditions, on the prevalence of respiratory diseases.</p><sec id="sec3dot6dot1-tropicalmed-10-00056"><title>3.6.1. Associations Between Air Pollution Markers and the Respiratory Disease Incidence Rates</title><p>The findings of this research reveal diverse associations between Air Quality Index (AQI), ambient ozone, and NO<sub>2</sub> concentrations, and the incidence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and tuberculosis across all countries.</p><p>For asthma, the analysis revealed no significant correlations with AQI across all countries, and in fact, a significant negative correlation was found with AQI for COPD. This surprising result&#x02014;indicating that poorer air quality may be associated with a lower prevalence of these conditions&#x02014;may be attributed to potential underreporting or discrepancies in data from high-pollution areas. As AQI is a composite measure, it could mask the effects of specific pollutants, leading to an observed negative relationship with disease incidence. Furthermore, factors such as local health systems, access to healthcare, and socioeconomic determinants may contribute to the lack of a clear association [<xref rid="B30-tropicalmed-10-00056" ref-type="bibr">30</xref>]. However, when accounting for socioeconomic factors, a significant negative correlation between AQI and COPD remained, suggesting that the observed effects were driven by confounding variables rather than a direct pollutant&#x02013;disease relationship.</p><p>In contrast, AQI exhibited a significant positive correlation with tuberculosis incidence across countries. This aligns with the hypothesis that air pollution could compromise immune function, increasing vulnerability to infections like tuberculosis. Similar findings have been observed in previous studies, where air pollution has been linked to respiratory infections by impairing lung function and weakening immune defenses [<xref rid="B31-tropicalmed-10-00056" ref-type="bibr">31</xref>,<xref rid="B32-tropicalmed-10-00056" ref-type="bibr">32</xref>]. The complex relationship between air pollution and tuberculosis incidence suggests that pollution may not directly cause tuberculosis, but could exacerbate the disease through weakened immune responses and heightened susceptibility in regions with elevated pollution levels.</p><p>Ambient ozone, in general, showed a negative correlation with asthma and COPD across all countries, but this relationship became insignificant after controlling for socioeconomic factors. Ozone is a known irritant that can contribute to airway inflammation, and it is plausible that in certain areas, the effects of ozone exposure are exacerbated by other environmental and social factors. However, after adjusting for confounders, the overall lack of significant findings suggests that the observed correlations between ozone and respiratory diseases may be largely influenced by socioeconomic factors.</p><p>The observed strong link between NO<sub>2</sub> levels and COPD aligns with previous research, which highlights NO<sub>2</sub> as a key contributor to lung inflammation and respiratory harm. NO<sub>2</sub> exposure is known to exacerbate COPD symptoms by promoting chronic inflammation and damaging airway tissues [<xref rid="B27-tropicalmed-10-00056" ref-type="bibr">27</xref>,<xref rid="B33-tropicalmed-10-00056" ref-type="bibr">33</xref>]. This study found that higher NO<sub>2</sub> levels were consistently associated with increased COPD incidence, confirming the harmful effects of NO<sub>2</sub> on respiratory health. In contrast, the generally negative correlation between NO<sub>2</sub> and tuberculosis incidence could reflect the complex dynamics of urbanization and healthcare access. Urban areas with higher NO<sub>2</sub> levels may also have better healthcare infrastructure, more effective TB control programs, and improved living conditions, which could reduce the risk of tuberculosis despite higher levels of pollution [<xref rid="B34-tropicalmed-10-00056" ref-type="bibr">34</xref>,<xref rid="B35-tropicalmed-10-00056" ref-type="bibr">35</xref>]. This suggests that the relationship between NO<sub>2</sub> and tuberculosis incidence is multifaceted and may depend on factors beyond pollution exposure alone.</p></sec><sec id="sec3dot6dot2-tropicalmed-10-00056"><title>3.6.2. Regional Variability in the Impact of Air Pollution on Respiratory Disease Incidence</title><p>The relationship between air pollution and respiratory diseases varies significantly across countries, reflecting the complex interplay of environmental exposure, healthcare infrastructure, and socioeconomic conditions. While broad trends suggest that poor air quality increases respiratory disease incidence, regional disparities highlight the need to consider local factors when interpreting these associations. In Japan, AQI showed a strong positive correlation with tuberculosis, a pattern also observed in Brazil, Portugal, and Angola. This suggests that high pollution levels may weaken immune defenses, increasing susceptibility to TB. However, this association was not seen in India, despite its high TB burden and pollution levels. This discrepancy could be due to differences in disease surveillance and reporting. Japan has a highly structured TB control program that ensures accurate detection, whereas underreporting in India, particularly in rural areas, may obscure this relationship. Additionally, Japan&#x02019;s aging population, concentrated in urban areas with higher pollution exposure, may contribute to increased TB susceptibility, whereas in India, malnutrition and co-infections play a more dominant role in TB transmission.</p><p>Variability in the association between ozone and COPD further underscores the role of local conditions. In Cambodia, Brazil, and South Africa, ozone levels were strongly correlated with COPD, likely due to widespread exposure to industrial emissions, biomass burning, and vehicle pollution. Limited healthcare access in these regions may exacerbate the impact of pollution on respiratory health. Conversely, countries such as Macedonia, Portugal, and Sweden showed a negative correlation, which could reflect stronger environmental regulations, lower exposure to extreme ozone levels, and better adaptation measures such as public health warnings on high-ozone days. Thailand presents an unexpected finding, where AQI was negatively correlated with COPD. This could be attributed to Thailand&#x02019;s strict air pollution control measures in major cities, which may have led to better respiratory outcomes. Additionally, improved healthcare access in less polluted regions could lead to higher COPD detection rates in these areas, artificially creating a negative association.</p><p>A similar pattern was observed in Germany and Costa Rica, where COPD diagnosis may be more prevalent in regions with lower pollution due to greater healthcare availability and awareness. Ozone&#x02019;s negative correlation with tuberculosis in Poland, Cambodia, Brazil, and Colombia raises questions about its potential antimicrobial properties. Some studies suggest that high ozone concentrations could reduce airborne pathogen viability, potentially lowering TB transmission rates in polluted urban areas [<xref rid="B36-tropicalmed-10-00056" ref-type="bibr">36</xref>,<xref rid="B37-tropicalmed-10-00056" ref-type="bibr">37</xref>]. Additionally, these countries have well-structured TB control programs that may counteract the expected negative health effects of pollution, leading to reduced TB incidence despite high ozone levels. These disparities emphasize the need for localized public health interventions. Countries with a strong AQI-TB correlation, such as Japan and Brazil, should integrate air pollution mitigation with TB prevention strategies. Nations with high ozone&#x02013;COPD associations, like Cambodia and Brazil, should focus on reducing industrial and vehicular emissions while expanding healthcare access for COPD patients. In regions like Thailand, where pollution control policies appear effective, further efforts should ensure equitable access to respiratory healthcare in both urban and rural settings.</p></sec><sec id="sec3dot6dot3-tropicalmed-10-00056"><title>3.6.3. Socioeconomic Factors: Influence on the Association Between Air Pollution and Respiratory Diseases</title><p>Socioeconomic factors like GDP per capita, tobacco smoking prevalence, and healthcare expenditure significantly influenced the associations between air pollutants and respiratory disease incidence. Higher GDP per capita showed a strong positive association with COPD, indicating that wealthier countries tend to report more cases, possibly due to better diagnostic practices or a longer life expectancy where COPD is more common. In contrast, GDP per capita was negatively associated with tuberculosis, suggesting that wealthier nations have better public health systems that can prevent or manage tuberculosis outbreaks. This finding aligns with previous research indicating that higher-income nations have more effective tuberculosis control measures, including vaccination programs, better access to healthcare, and improved living conditions consistent with previous studies [<xref rid="B35-tropicalmed-10-00056" ref-type="bibr">35</xref>,<xref rid="B38-tropicalmed-10-00056" ref-type="bibr">38</xref>]. These factors likely contribute to a reduced burden of tuberculosis in wealthier nations, despite the potential for increased exposure to pollution in urbanized areas.</p><p>Healthcare expenditure showed a positive correlation with asthma and COPD but a negative correlation with tuberculosis, reflecting better treatment and management for chronic conditions but effective preventive measures for infectious diseases like tuberculosis in countries with higher healthcare spending. Tobacco smoking prevalence, a well-known risk factor, was positively associated with COPD across all countries, highlighting the crucial role of smoking cessation in reducing COPD incidence [<xref rid="B38-tropicalmed-10-00056" ref-type="bibr">38</xref>]. However, its negative association with asthma may reflect the decreasing smoking rates in countries with higher asthma rates due to successful public health campaigns against smoking.</p></sec><sec id="sec3dot6dot4-tropicalmed-10-00056"><title>3.6.4. Impact of Pollution Periods on Respiratory Diseases</title><p>The findings of this study demonstrate a clear association between periods of elevated pollution and increased incidence rates of COPD and tuberculosis, while asthma did not show a significant connection with these pollution periods. Specifically, elevated AQI and NO<sub>2</sub> levels were strongly correlated with higher rates of COPD and tuberculosis, suggesting that periods of high pollution may exacerbate or trigger the onset of these respiratory conditions. This supports the hypothesis that pollution surges have a detrimental impact on respiratory health, particularly in vulnerable populations, where exposure to poor air quality can worsen existing conditions or lead to new diagnoses.</p><p>Previous research also supports the notion that short-term pollution spikes have a more pronounced effect on conditions like COPD and tuberculosis, which involve chronic inflammation and long-term damage to lung tissue [<xref rid="B24-tropicalmed-10-00056" ref-type="bibr">24</xref>,<xref rid="B39-tropicalmed-10-00056" ref-type="bibr">39</xref>]. The cumulative nature of COPD, which involves ongoing damage to the airways, makes individuals with this condition more susceptible to the harmful effects of elevated pollution. Similarly, tuberculosis, an infectious disease, can become more severe in individuals living in polluted environments, as air pollution may impair lung defenses and increase susceptibility to infections [<xref rid="B3-tropicalmed-10-00056" ref-type="bibr">3</xref>,<xref rid="B7-tropicalmed-10-00056" ref-type="bibr">7</xref>,<xref rid="B8-tropicalmed-10-00056" ref-type="bibr">8</xref>].</p></sec></sec><sec id="sec3dot7-tropicalmed-10-00056"><title>3.7. Limitations of the Study</title><p>Although this study gives important insights into the associations between air pollution and respiratory disease incidence rates, the cross-sectional design of this research limits its ability to draw causal inferences. Also, several confounders such as urbanization, occupational exposures, indoor air pollution, and genetic factors were not accounted for in the study.</p></sec><sec id="sec3dot8-tropicalmed-10-00056"><title>3.8. Recommendations for Future Research</title><p>Future research should implement longitudinal designs to shed light on the causal relationships between air pollution exposure and the incidence of respiratory diseases over time, thereby facilitating a more comprehensive understanding of the long-term effects of pollution and the efficacy of pollution control measures. Additionally, increasing the temporal and geographic granularity such as monthly or seasonal data and conducting subnational analyses, could offer deeper insights into how short-term pollution changes and local conditions impact respiratory health. Accounting for a wider range of confounders, especially those excluded in this study, would also help isolate the specific effects of outdoor pollution. Examining these factors might facilitate future studies in understanding the relationship between air pollution and respiratory health, hence providing more robust evidence for successful public health interventions and policy formulation.</p></sec></sec><sec sec-type="conclusions" id="sec4-tropicalmed-10-00056"><title>4. Conclusions</title><p>This study explored the associations between respiratory disease incidence, air pollution markers, and socioeconomic factors. The findings provide evidence that the incidence of respiratory diseases is influenced by a combination of air pollution levels and socioeconomic conditions, highlighting that a multifactorial approach is needed to mitigate respiratory disease incidence.</p><p>Policymakers must enforce stricter emission regulations, promote cleaner energy solutions, and invest in sustainable transportation options to reduce air pollution levels. In addition to these traditional regulatory measures, real-time pollution monitoring, smart infrastructure, and incentives for cleaner technologies should be considered. Governments should integrate pollution-responsive urban planning, including air-filtering buildings and green ventilation corridors, to reduce exposure in high-risk areas.</p><p>In countries with lower economic resources and high smoking prevalence, strengthening healthcare infrastructure is essential for managing respiratory conditions more effectively. Early detection and management of pollution-related diseases must be prioritized. Decentralizing respiratory care through mobile clinics and expanding insurance coverage for pollution-induced illnesses would improve access to treatment. Workplace screening for respiratory diseases in high-risk industries and subsidized access to protective measures (such as indoor air purification systems) could further reduce health disparities. Additionally, public health initiatives aimed at reducing tobacco consumption should work in tandem with pollution reduction efforts, as smoking intensifies the harmful effects of poor air quality. Tobacco control policies require a shift from traditional taxation to integrated cessation programs within primary healthcare services. Trade restrictions on low-cost, high-toxicity tobacco products and economic incentives for transitioning workers away from tobacco production could strengthen public health efforts.</p><p>Material science innovations should also be leveraged. The adoption of pollution-absorbing building materials, photocatalytic coatings, and genetically enhanced air-purifying plants could transform urban spaces into active pollution mitigators. Governments should support research into affordable, scalable solutions that can be implemented in both high- and low-income regions</p><p>Addressing these interconnected challenges can significantly improve respiratory health outcomes and reduce the overall disease burden. In conclusion, both air pollution and healthcare gaps must be addressed to ensure the global burden of respiratory disease is reduced. Governments and health organizations must act swiftly to implement policies that improve air quality and strengthen healthcare systems, particularly in vulnerable, low-income regions.</p></sec></body><back><ack><title>Acknowledgments</title><p>The author appreciates the continuous support of the University of Hafr Al Batin.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The links for the raw data required to reproduce these findings are provided in <xref rid="sec2dot3-tropicalmed-10-00056" ref-type="sec">Section 2.3</xref>.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The author declares no conflicts of interest.</p></notes><app-group><app id="app1-tropicalmed-10-00056"><title>Appendix A</title><p>List of countries used in this study.</p><list list-type="order"><list-item><p>Japan</p></list-item><list-item><p>Australia</p></list-item><list-item><p>Poland</p></list-item><list-item><p>Thailand</p></list-item><list-item><p>Macedonia</p></list-item><list-item><p>Germany</p></list-item><list-item><p>Cambodia</p></list-item><list-item><p>Costa Rica</p></list-item><list-item><p>New Zealand</p></list-item><list-item><p>Canada</p></list-item><list-item><p>Portugal</p></list-item><list-item><p>Sweden</p></list-item><list-item><p>Brazil</p></list-item><list-item><p>Mexico</p></list-item><list-item><p>Chile</p></list-item><list-item><p>Colombia</p></list-item><list-item><p>United Kingdom</p></list-item><list-item><p>United States</p></list-item><list-item><p>Argentina</p></list-item><list-item><p>Turkey</p></list-item><list-item><p>India</p></list-item><list-item><p>Ethiopia</p></list-item><list-item><p>Pakistan</p></list-item><list-item><p>South Africa</p></list-item><list-item><p>Nigeria</p></list-item><list-item><p>Bangladesh</p></list-item><list-item><p>Angola</p></list-item></list></app></app-group><ref-list><title>References</title><ref id="B1-tropicalmed-10-00056"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fuller</surname><given-names>R.</given-names></name>
<name><surname>Landrigan</surname><given-names>P.J.</given-names></name>
<name><surname>Balakrishnan</surname><given-names>K.</given-names></name>
<name><surname>Bathan</surname><given-names>G.</given-names></name>
<name><surname>Bose-O&#x02019;Reilly</surname><given-names>S.</given-names></name>
<name><surname>Brauer</surname><given-names>M.</given-names></name>
<name><surname>Caravanos</surname><given-names>J.</given-names></name>
<name><surname>Chiles</surname><given-names>T.</given-names></name>
<name><surname>Cohen</surname><given-names>A.</given-names></name>
<name><surname>Corra</surname><given-names>L.</given-names></name>
<etal/>
</person-group><article-title>Pollution and health: A progress update</article-title><source>Lancet Planet. Health</source><year>2022</year><volume>6</volume><fpage>e535</fpage><lpage>e547</lpage><pub-id pub-id-type="doi">10.1016/S2542-5196(22)00090-0</pub-id><pub-id pub-id-type="pmid">35594895</pub-id>
</element-citation></ref><ref id="B2-tropicalmed-10-00056"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Manisalidis</surname><given-names>I.</given-names></name>
<name><surname>Stavropoulou</surname><given-names>E.</given-names></name>
<name><surname>Stavropoulos</surname><given-names>A.</given-names></name>
<name><surname>Bezirtzoglou</surname><given-names>E.</given-names></name>
</person-group><article-title>Environmental and Health Impacts of Air Pollution: A Review</article-title><source>Front. Public Health</source><year>2020</year><volume>8</volume><elocation-id>505570</elocation-id><pub-id pub-id-type="doi">10.3389/fpubh.2020.00014</pub-id><pub-id pub-id-type="pmid">32154200</pub-id>
</element-citation></ref><ref id="B3-tropicalmed-10-00056"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wiegman</surname><given-names>C.H.</given-names></name>
<name><surname>Li</surname><given-names>F.</given-names></name>
<name><surname>Ryffel</surname><given-names>B.</given-names></name>
<name><surname>Togbe</surname><given-names>D.</given-names></name>
<name><surname>Chung</surname><given-names>K.F.</given-names></name>
</person-group><article-title>Oxidative Stress in Ozone-Induced Chronic Lung Inflammation and Emphysema: A Facet of Chronic Obstructive Pulmonary Disease</article-title><source>Front. Immunol.</source><year>2020</year><volume>11</volume><elocation-id>1957</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.01957</pub-id><pub-id pub-id-type="pmid">32983127</pub-id>
</element-citation></ref><ref id="B4-tropicalmed-10-00056"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Enweasor</surname><given-names>C.</given-names></name>
<name><surname>Flayer</surname><given-names>C.H.</given-names></name>
<name><surname>Haczku</surname><given-names>A.</given-names></name>
</person-group><article-title>Ozone-Induced Oxidative Stress, Neutrophilic Airway Inflammation, and Glucocorticoid Resistance in Asthma</article-title><source>Front. Immunol.</source><year>2021</year><volume>12</volume><elocation-id>631092</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2021.631092</pub-id><pub-id pub-id-type="pmid">33717165</pub-id>
</element-citation></ref><ref id="B5-tropicalmed-10-00056"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>M.-S.</given-names></name>
<name><surname>Lim</surname><given-names>Y.-H.</given-names></name>
<name><surname>Oh</surname><given-names>J.</given-names></name>
<name><surname>Myung</surname><given-names>J.</given-names></name>
<name><surname>Han</surname><given-names>C.</given-names></name>
<name><surname>Bae</surname><given-names>H.-J.</given-names></name>
<name><surname>Kim</surname><given-names>S.</given-names></name>
<name><surname>Hong</surname><given-names>Y.-C.</given-names></name>
<name><surname>Lee</surname><given-names>D.-W.</given-names></name>
</person-group><article-title>Long-Term Ozone Exposure, COPD, and Asthma Mortality: A Retrospective Cohort Study in the Republic of Korea</article-title><source>Atmosphere</source><year>2024</year><volume>15</volume><elocation-id>1340</elocation-id><pub-id pub-id-type="doi">10.3390/atmos15111340</pub-id></element-citation></ref><ref id="B6-tropicalmed-10-00056"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Duan</surname><given-names>R.</given-names></name>
<name><surname>Hao</surname><given-names>K.</given-names></name>
<name><surname>Yang</surname><given-names>T.</given-names></name>
</person-group><article-title>Air pollution and chronic obstructive pulmonary disease</article-title><source>Chronic Dis. Transl. Med.</source><year>2020</year><volume>6</volume><fpage>260</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1016/j.cdtm.2020.05.004</pub-id><pub-id pub-id-type="pmid">33336171</pub-id>
</element-citation></ref><ref id="B7-tropicalmed-10-00056"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>M.</given-names></name>
<name><surname>Aaron</surname><given-names>C.P.</given-names></name>
<name><surname>Madrigano</surname><given-names>J.</given-names></name>
<name><surname>Hoffman</surname><given-names>E.A.</given-names></name>
<name><surname>Angelini</surname><given-names>E.</given-names></name>
<name><surname>Yang</surname><given-names>J.</given-names></name>
<name><surname>Laine</surname><given-names>A.</given-names></name>
<name><surname>Vetterli</surname><given-names>T.M.</given-names></name>
<name><surname>Kinney</surname><given-names>P.L.</given-names></name>
<name><surname>Sampson</surname><given-names>P.D.</given-names></name>
<etal/>
</person-group><article-title>Association Between Long-term Exposure to Ambient Air Pollution and Change in Quantitatively Assessed Emphysema and Lung Function</article-title><source>JAMA</source><year>2019</year><volume>322</volume><fpage>546</fpage><lpage>556</lpage><pub-id pub-id-type="doi">10.1001/jama.2019.10255</pub-id><pub-id pub-id-type="pmid">31408135</pub-id>
</element-citation></ref><ref id="B8-tropicalmed-10-00056"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Altug</surname><given-names>H.</given-names></name>
<name><surname>Lucht</surname><given-names>S.</given-names></name>
<name><surname>Tzivian</surname><given-names>L.</given-names></name>
<name><surname>Ogurtsova</surname><given-names>K.</given-names></name>
<name><surname>Ofenheimer</surname><given-names>A.</given-names></name>
<name><surname>Karimi</surname><given-names>A.</given-names></name>
<name><surname>Azizzadeh</surname><given-names>M.</given-names></name>
<name><surname>Mraz</surname><given-names>T.</given-names></name>
<name><surname>Wouters</surname><given-names>E.F.</given-names></name>
<name><surname>Hartl</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Associations between long-term exposure to air pollution and lung function in the LEAD general population study</article-title><source>Eur. Respir. J.</source><year>2024</year><volume>64</volume><fpage>PA3129</fpage><pub-id pub-id-type="doi">10.1183/13993003.congress-2024.PA3129</pub-id></element-citation></ref><ref id="B9-tropicalmed-10-00056"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ko</surname><given-names>U.W.</given-names></name>
<name><surname>Kyung</surname><given-names>S.Y.</given-names></name>
</person-group><article-title>Adverse Effects of Air Pollution on Pulmonary Diseases</article-title><source>Tuberc. Respir. Dis.</source><year>2022</year><volume>85</volume><fpage>313</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.4046/trd.2022.0116</pub-id></element-citation></ref><ref id="B10-tropicalmed-10-00056"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gaffney</surname><given-names>A.W.</given-names></name>
<name><surname>Himmelstein</surname><given-names>D.U.</given-names></name>
<name><surname>Christiani</surname><given-names>D.C.</given-names></name>
<name><surname>Woolhandler</surname><given-names>S.</given-names></name>
</person-group><article-title>Socioeconomic Inequality in Respiratory Health in the US From 1959 to 2018</article-title><source>JAMA Intern. Med.</source><year>2021</year><volume>181</volume><fpage>968</fpage><lpage>976</lpage><pub-id pub-id-type="doi">10.1001/jamainternmed.2021.2441</pub-id><pub-id pub-id-type="pmid">34047754</pub-id>
</element-citation></ref><ref id="B11-tropicalmed-10-00056"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schikowski</surname><given-names>T.</given-names></name>
<name><surname>Sugiri</surname><given-names>D.</given-names></name>
<name><surname>Reimann</surname><given-names>V.</given-names></name>
<name><surname>Pesch</surname><given-names>B.</given-names></name>
<name><surname>Ranft</surname><given-names>U.</given-names></name>
<name><surname>Kr&#x000e4;mer</surname><given-names>U.</given-names></name>
</person-group><article-title>Contribution of smoking and air pollution exposure in urban areas to social differences in respiratory health</article-title><source>BMC Public Health</source><year>2008</year><volume>8</volume><elocation-id>179</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2458-8-179</pub-id><pub-id pub-id-type="pmid">18505547</pub-id>
</element-citation></ref><ref id="B12-tropicalmed-10-00056"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rentschler</surname><given-names>J.</given-names></name>
<name><surname>Leonova</surname><given-names>N.</given-names></name>
</person-group><article-title>Global air pollution exposure and poverty</article-title><source>Nat. Commun.</source><year>2023</year><volume>14</volume><fpage>4432</fpage><pub-id pub-id-type="doi">10.1038/s41467-023-39797-4</pub-id><pub-id pub-id-type="pmid">37481598</pub-id>
</element-citation></ref><ref id="B13-tropicalmed-10-00056"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Amegah</surname><given-names>A.K.</given-names></name>
<name><surname>Jaakkola</surname><given-names>J.J.</given-names></name>
</person-group><article-title>Household air pollution and the sustainable development goals</article-title><source>Bull. World Health Organ.</source><year>2016</year><volume>94</volume><fpage>215</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.2471/BLT.15.155812</pub-id><pub-id pub-id-type="pmid">26966333</pub-id>
</element-citation></ref><ref id="B14-tropicalmed-10-00056"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Okhovat-Isfahani</surname><given-names>B.</given-names></name>
<name><surname>Bitaraf</surname><given-names>S.</given-names></name>
<name><surname>Mansournia</surname><given-names>M.A.</given-names></name>
<name><surname>Doosti-Irani</surname><given-names>A.</given-names></name>
</person-group><article-title>Inequality in the global incidence and prevalence of tuberculosis (TB) and TB/HIV according to the human development index</article-title><source>Med. J. Islam. Repub. Iran</source><year>2019</year><volume>33</volume><fpage>275</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.47176/mjiri.33.45</pub-id></element-citation></ref><ref id="B15-tropicalmed-10-00056"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rodriguez</surname><given-names>A.</given-names></name>
<name><surname>Brickley</surname><given-names>E.</given-names></name>
<name><surname>Rodrigues</surname><given-names>L.</given-names></name>
<name><surname>Normansell</surname><given-names>R.A.</given-names></name>
<name><surname>Barreto</surname><given-names>M.</given-names></name>
<name><surname>Cooper</surname><given-names>P.J.</given-names></name>
</person-group><article-title>Urbanisation and asthma in low-income and middle-income countries: A systematic review of the urban&#x02013;rural differences in asthma prevalence</article-title><source>Thorax</source><year>2019</year><volume>74</volume><fpage>1020</fpage><lpage>1030</lpage><pub-id pub-id-type="doi">10.1136/thoraxjnl-2018-211793</pub-id><pub-id pub-id-type="pmid">31278168</pub-id>
</element-citation></ref><ref id="B16-tropicalmed-10-00056"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jie</surname><given-names>Y.</given-names></name>
<name><surname>Ismail</surname><given-names>N.H.</given-names></name>
<name><surname>Jie</surname><given-names>X.</given-names></name>
<name><surname>Isa</surname><given-names>Z.M.</given-names></name>
</person-group><article-title>Do indoor environments influence asthma and asthma-related symptoms among adults in homes? A review of the literature</article-title><source>J. Formos. Med. Assoc.</source><year>2011</year><volume>110</volume><fpage>555</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1016/j.jfma.2011.07.003</pub-id><pub-id pub-id-type="pmid">21930065</pub-id>
</element-citation></ref><ref id="B17-tropicalmed-10-00056"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Laniado-Labor&#x000ed;n</surname><given-names>R.</given-names></name>
</person-group><article-title>Smoking and chronic obstructive pulmonary disease (COPD). Parallel Epidemics of the 21st Century</article-title><source>Int. J. Environ. Res. Public Health</source><year>2009</year><volume>6</volume><fpage>209</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.3390/ijerph6010209</pub-id><pub-id pub-id-type="pmid">19440278</pub-id>
</element-citation></ref><ref id="B18-tropicalmed-10-00056"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Adatia</surname><given-names>A.</given-names></name>
<name><surname>Wahab</surname><given-names>M.</given-names></name>
<name><surname>Shahid</surname><given-names>I.</given-names></name>
<name><surname>Moinuddin</surname><given-names>A.</given-names></name>
<name><surname>Killian</surname><given-names>K.J.</given-names></name>
<name><surname>Satia</surname><given-names>I.</given-names></name>
</person-group><article-title>Effects of cigarette smoke exposure on pulmonary physiology, muscle strength and exercise capacity in a retrospective cohort with 30,000 subjects</article-title><source>PLoS ONE</source><year>2021</year><volume>16</volume><elocation-id>e0250957</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0250957</pub-id><pub-id pub-id-type="pmid">34166381</pub-id>
</element-citation></ref><ref id="B19-tropicalmed-10-00056"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yan</surname><given-names>M.</given-names></name>
<name><surname>Gong</surname><given-names>J.</given-names></name>
<name><surname>Liu</surname><given-names>Q.</given-names></name>
<name><surname>Li</surname><given-names>W.</given-names></name>
<name><surname>Duan</surname><given-names>X.</given-names></name>
<name><surname>Cao</surname><given-names>S.</given-names></name>
<name><surname>Li</surname><given-names>S.</given-names></name>
<name><surname>He</surname><given-names>L.</given-names></name>
<name><surname>Yin</surname><given-names>Z.</given-names></name>
<name><surname>Lin</surname><given-names>W.</given-names></name>
<etal/>
</person-group><article-title>Prevalence of respiratory diseases in relation to smoking rate in adults living in four Chinese cities: A comparison between 2017&#x02013; 2018 and 1993&#x02013;1996</article-title><source>J. Thorac. Dis.</source><year>2020</year><volume>12</volume><fpage>6315</fpage><lpage>6326</lpage><pub-id pub-id-type="doi">10.21037/jtd-19-crh-aq-002</pub-id><pub-id pub-id-type="pmid">33209471</pub-id>
</element-citation></ref><ref id="B20-tropicalmed-10-00056"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Momtazmanesh</surname><given-names>S.</given-names></name>
<name><surname>Moghaddam</surname><given-names>S.S.</given-names></name>
<name><surname>Ghamari</surname><given-names>S.-H.</given-names></name>
<name><surname>Rad</surname><given-names>E.M.</given-names></name>
<name><surname>Rezaei</surname><given-names>N.</given-names></name>
<name><surname>Shobeiri</surname><given-names>P.</given-names></name>
<name><surname>Aali</surname><given-names>A.</given-names></name>
<name><surname>Abbasi-Kangevari</surname><given-names>M.</given-names></name>
<name><surname>Abbasi-Kangevari</surname><given-names>Z.</given-names></name>
<name><surname>Abdelmasseh</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Global burden of chronic respiratory diseases and risk factors, 1990&#x02013;2019: An update from the Global Burden of Disease Study 2019</article-title><source>EClinicalMedicine</source><year>2023</year><volume>59</volume><fpage>101936</fpage><pub-id pub-id-type="doi">10.1016/j.eclinm.2023.101936</pub-id><pub-id pub-id-type="pmid">37229504</pub-id>
</element-citation></ref><ref id="B21-tropicalmed-10-00056"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ivankova</surname><given-names>V.</given-names></name>
<name><surname>Gavurova</surname><given-names>B.</given-names></name>
<name><surname>Khouri</surname><given-names>S.</given-names></name>
</person-group><article-title>Understanding the relationships between health spending, treatable mortality and economic productivity in OECD countries</article-title><source>Front. Public Health</source><year>2022</year><volume>10</volume><elocation-id>1036058</elocation-id><pub-id pub-id-type="doi">10.3389/fpubh.2022.1036058</pub-id><pub-id pub-id-type="pmid">36620274</pub-id>
</element-citation></ref><ref id="B22-tropicalmed-10-00056"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Khomenko</surname><given-names>S.</given-names></name>
<name><surname>Cirach</surname><given-names>M.</given-names></name>
<name><surname>Pereira-Barboza</surname><given-names>E.</given-names></name>
<name><surname>Mueller</surname><given-names>N.</given-names></name>
<name><surname>Barrera-G&#x000f3;mez</surname><given-names>J.</given-names></name>
<name><surname>Rojas-Rueda</surname><given-names>D.</given-names></name>
<name><surname>de Hoogh</surname><given-names>K.</given-names></name>
<name><surname>Hoek</surname><given-names>G.</given-names></name>
<name><surname>Nieuwenhuijsen</surname><given-names>M.</given-names></name>
</person-group><article-title>Premature mortality due to air pollution in European cities: A health impact assessment</article-title><source>Lancet Planet. Health</source><year>2021</year><volume>5</volume><fpage>e121</fpage><lpage>e134</lpage><pub-id pub-id-type="doi">10.1016/S2542-5196(20)30272-2</pub-id><pub-id pub-id-type="pmid">33482109</pub-id>
</element-citation></ref><ref id="B23-tropicalmed-10-00056"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Park</surname><given-names>J.</given-names></name>
<name><surname>Kim</surname><given-names>H.-J.</given-names></name>
<name><surname>Lee</surname><given-names>C.H.</given-names></name>
<name><surname>Lee</surname><given-names>H.W.</given-names></name>
</person-group><article-title>Impact of long-term exposure to ambient air pollution on the incidence of chronic obstructive pulmonary disease: A systematic review and meta-analysis</article-title><source>Environ. Res.</source><year>2021</year><volume>194</volume><fpage>110703</fpage><pub-id pub-id-type="doi">10.1016/j.envres.2020.110703</pub-id><pub-id pub-id-type="pmid">33417909</pub-id>
</element-citation></ref><ref id="B24-tropicalmed-10-00056"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>S.</given-names></name>
<name><surname>Xiang</surname><given-names>H.</given-names></name>
<name><surname>Yang</surname><given-names>W.</given-names></name>
<name><surname>Zhu</surname><given-names>Z.</given-names></name>
<name><surname>Tian</surname><given-names>L.</given-names></name>
<name><surname>Deng</surname><given-names>S.</given-names></name>
<name><surname>Zhang</surname><given-names>T.</given-names></name>
<name><surname>Lu</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>F.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<etal/>
</person-group><article-title>Short-Term Effect of Air Pollution on Tuberculosis Based on Kriged Data: A Time-Series Analysis</article-title><source>Int. J. Environ. Res. Public Health</source><year>2020</year><volume>17</volume><elocation-id>1522</elocation-id><pub-id pub-id-type="doi">10.3390/ijerph17051522</pub-id><pub-id pub-id-type="pmid">32120876</pub-id>
</element-citation></ref><ref id="B25-tropicalmed-10-00056"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Peptenatu</surname><given-names>D.</given-names></name>
<name><surname>B&#x00103;loi</surname><given-names>A.M.</given-names></name>
<name><surname>Andronic</surname><given-names>O.</given-names></name>
<name><surname>Bolocan</surname><given-names>A.</given-names></name>
<name><surname>Cioran</surname><given-names>N.</given-names></name>
<name><surname>Gruia</surname><given-names>A.K.</given-names></name>
<name><surname>Grecu</surname><given-names>A.</given-names></name>
<name><surname>Panciu</surname><given-names>T.C.</given-names></name>
<name><surname>Georgescu</surname><given-names>L.</given-names></name>
<name><surname>Munteanu</surname><given-names>I.</given-names></name>
<etal/>
</person-group><article-title>Spatio-Temporal Pattern of Tuberculosis Distribution in Romania and Particulate Matter Pollution Associated With Risk of Infection</article-title><source>GeoHealth</source><year>2024</year><volume>8</volume><fpage>e2023GH000972</fpage><pub-id pub-id-type="doi">10.1029/2023GH000972</pub-id></element-citation></ref><ref id="B26-tropicalmed-10-00056"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dimakopoulou</surname><given-names>K.</given-names></name>
<name><surname>Douros</surname><given-names>J.</given-names></name>
<name><surname>Samoli</surname><given-names>E.</given-names></name>
<name><surname>Karakatsani</surname><given-names>A.</given-names></name>
<name><surname>Rodopoulou</surname><given-names>S.</given-names></name>
<name><surname>Papakosta</surname><given-names>D.</given-names></name>
<name><surname>Grivas</surname><given-names>G.</given-names></name>
<name><surname>Tsilingiridis</surname><given-names>G.</given-names></name>
<name><surname>Mudway</surname><given-names>I.</given-names></name>
<name><surname>Moussiopoulos</surname><given-names>N.</given-names></name>
<etal/>
</person-group><article-title>Long-term exposure to ozone and children&#x02019;s respiratory health: Results from the RESPOZE study</article-title><source>Environ. Res.</source><year>2019</year><volume>182</volume><fpage>109002</fpage><pub-id pub-id-type="doi">10.1016/j.envres.2019.109002</pub-id><pub-id pub-id-type="pmid">31855698</pub-id>
</element-citation></ref><ref id="B27-tropicalmed-10-00056"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Saki</surname><given-names>H.</given-names></name>
<name><surname>Goudarzi</surname><given-names>G.</given-names></name>
<name><surname>Jalali</surname><given-names>S.</given-names></name>
<name><surname>Barzegar</surname><given-names>G.</given-names></name>
<name><surname>Farhadi</surname><given-names>M.</given-names></name>
<name><surname>Parseh</surname><given-names>I.</given-names></name>
<name><surname>Geravandi</surname><given-names>S.</given-names></name>
<name><surname>Salmanzadeh</surname><given-names>S.</given-names></name>
<name><surname>Yousefi</surname><given-names>F.</given-names></name>
<name><surname>Mohammadi</surname><given-names>M.J.</given-names></name>
</person-group><article-title>Study of relationship between nitrogen dioxide and chronic obstructive pulmonary disease in Bushehr, Iran</article-title><source>Clin. Epidemiol. Glob. Health</source><year>2020</year><volume>8</volume><fpage>446</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.1016/j.cegh.2019.10.006</pub-id></element-citation></ref><ref id="B28-tropicalmed-10-00056"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wenig</surname><given-names>J.R.</given-names></name>
<name><surname>Erfurt</surname><given-names>L.</given-names></name>
<name><surname>Kroger</surname><given-names>C.B.</given-names></name>
<name><surname>Nowak</surname><given-names>D.</given-names></name>
</person-group><article-title>Smoking cessation in groups--who benefits in the long term?</article-title><source>Health Educ. Res.</source><year>2013</year><volume>28</volume><fpage>869</fpage><lpage>878</lpage><pub-id pub-id-type="doi">10.1093/her/cyt086</pub-id><pub-id pub-id-type="pmid">23962493</pub-id>
</element-citation></ref><ref id="B29-tropicalmed-10-00056"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>Q.-Y.</given-names></name>
<name><surname>Yang</surname><given-names>D.-M.</given-names></name>
<name><surname>Cao</surname><given-names>L.-Q.</given-names></name>
<name><surname>Liu</surname><given-names>J.-Y.</given-names></name>
<name><surname>Tao</surname><given-names>N.-N.</given-names></name>
<name><surname>Li</surname><given-names>Y.-F.</given-names></name>
<name><surname>Liu</surname><given-names>Y.</given-names></name>
<name><surname>Xu</surname><given-names>T.-T.</given-names></name>
<name><surname>Li</surname><given-names>S.-J.</given-names></name>
<name><surname>An</surname><given-names>Q.-Q.</given-names></name>
<etal/>
</person-group><article-title>Association between economic development level and tuberculosis registered incidence in Shandong, China</article-title><source>BMC Public Health</source><year>2020</year><volume>20</volume><elocation-id>1557</elocation-id><pub-id pub-id-type="doi">10.1186/s12889-020-09627-z</pub-id><pub-id pub-id-type="pmid">33066742</pub-id>
</element-citation></ref><ref id="B30-tropicalmed-10-00056"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brunekreef</surname><given-names>B.</given-names></name>
<name><surname>Holgate</surname><given-names>S.T.</given-names></name>
</person-group><article-title>Air pollution and health</article-title><source>Lancet</source><year>2002</year><volume>360</volume><fpage>1233</fpage><lpage>1242</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(02)11274-8</pub-id><pub-id pub-id-type="pmid">12401268</pub-id>
</element-citation></ref><ref id="B31-tropicalmed-10-00056"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Horne</surname><given-names>B.D.</given-names></name>
<name><surname>Joy</surname><given-names>E.A.</given-names></name>
<name><surname>Hofmann</surname><given-names>M.G.</given-names></name>
<name><surname>Gesteland</surname><given-names>P.H.</given-names></name>
<name><surname>Cannon</surname><given-names>J.B.</given-names></name>
<name><surname>Lefler</surname><given-names>J.S.</given-names></name>
<name><surname>Blagev</surname><given-names>D.P.</given-names></name>
<name><surname>Korgenski</surname><given-names>E.K.</given-names></name>
<name><surname>Torosyan</surname><given-names>N.</given-names></name>
<name><surname>Hansen</surname><given-names>G.I.</given-names></name>
<etal/>
</person-group><article-title>Short-Term Elevation of Fine Particulate Matter Air Pollution and Acute Lower Respiratory Infection</article-title><source>Am. J. Respir. Crit. Care Med.</source><year>2018</year><volume>198</volume><fpage>759</fpage><lpage>766</lpage><pub-id pub-id-type="doi">10.1164/rccm.201709-1883OC</pub-id><pub-id pub-id-type="pmid">29652174</pub-id>
</element-citation></ref><ref id="B32-tropicalmed-10-00056"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tran</surname><given-names>H.M.</given-names></name>
<name><surname>Tsai</surname><given-names>F.-J.</given-names></name>
<name><surname>Lee</surname><given-names>Y.-L.</given-names></name>
<name><surname>Chang</surname><given-names>J.-H.</given-names></name>
<name><surname>Chang</surname><given-names>L.-T.</given-names></name>
<name><surname>Chang</surname><given-names>T.-Y.</given-names></name>
<name><surname>Chung</surname><given-names>K.F.</given-names></name>
<name><surname>Kuo</surname><given-names>H.-P.</given-names></name>
<name><surname>Lee</surname><given-names>K.-Y.</given-names></name>
<name><surname>Chuang</surname><given-names>K.-J.</given-names></name>
<etal/>
</person-group><article-title>The impact of air pollution on respiratory diseases in an era of climate change: A review of the current evidence</article-title><source>Sci. Total. Environ.</source><year>2023</year><volume>898</volume><fpage>166340</fpage><pub-id pub-id-type="doi">10.1016/j.scitotenv.2023.166340</pub-id><pub-id pub-id-type="pmid">37591374</pub-id>
</element-citation></ref><ref id="B33-tropicalmed-10-00056"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>L.</given-names></name>
<name><surname>Xie</surname><given-names>J.</given-names></name>
<name><surname>Hu</surname><given-names>Y.</given-names></name>
<name><surname>Tian</surname><given-names>Y.</given-names></name>
</person-group><article-title>Air pollution and risk of chronic obstructed pulmonary disease: The modifying effect of genetic susceptibility and lifestyle</article-title><source>EBioMedicine</source><year>2022</year><volume>79</volume><elocation-id>103994</elocation-id><pub-id pub-id-type="doi">10.1016/j.ebiom.2022.103994</pub-id><pub-id pub-id-type="pmid">35417845</pub-id>
</element-citation></ref><ref id="B34-tropicalmed-10-00056"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Murray</surname><given-names>M.</given-names></name>
<name><surname>Oxlade</surname><given-names>O.</given-names></name>
<name><surname>Lin</surname><given-names>H.-H.</given-names></name>
</person-group><article-title>Modeling social, environmental and biological determinants of tuberculosis</article-title><source>Int. J. Tuberc. Lung Dis.</source><year>2011</year><volume>15</volume><fpage>64</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.5588/ijtld.10.0535</pub-id><pub-id pub-id-type="pmid">21740661</pub-id>
</element-citation></ref><ref id="B35-tropicalmed-10-00056"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>Z.</given-names></name>
<name><surname>Zhao</surname><given-names>M.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Feng</surname><given-names>Y.</given-names></name>
</person-group><article-title>How does urbanization affect public health? New evidence from 175 countries worldwide</article-title><source>Front. Public Health</source><year>2023</year><volume>10</volume><elocation-id>1096964</elocation-id><pub-id pub-id-type="doi">10.3389/fpubh.2022.1096964</pub-id><pub-id pub-id-type="pmid">36684862</pub-id>
</element-citation></ref><ref id="B36-tropicalmed-10-00056"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Epelle</surname><given-names>E.I.</given-names></name>
<name><surname>Macfarlane</surname><given-names>A.</given-names></name>
<name><surname>Cusack</surname><given-names>M.</given-names></name>
<name><surname>Burns</surname><given-names>A.</given-names></name>
<name><surname>Thissera</surname><given-names>B.</given-names></name>
<name><surname>Mackay</surname><given-names>W.</given-names></name>
<name><surname>Rateb</surname><given-names>M.E.</given-names></name>
<name><surname>Yaseen</surname><given-names>M.</given-names></name>
</person-group><article-title>Bacterial and fungal disinfection via ozonation in air</article-title><source>J. Microbiol. Methods</source><year>2022</year><volume>194</volume><elocation-id>106431</elocation-id><pub-id pub-id-type="doi">10.1016/j.mimet.2022.106431</pub-id><pub-id pub-id-type="pmid">35131364</pub-id>
</element-citation></ref><ref id="B37-tropicalmed-10-00056"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Farooq</surname><given-names>S.</given-names></name>
<name><surname>Tizaoui</surname><given-names>C.</given-names></name>
</person-group><article-title>A critical review on the inactivation of surface and airborne SARS-CoV-2 virus by ozone gas</article-title><source>Crit. Rev. Environ. Sci. Technol.</source><year>2023</year><volume>53</volume><fpage>87</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1080/10643389.2022.2043094</pub-id></element-citation></ref><ref id="B38-tropicalmed-10-00056"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Burney</surname><given-names>P.G.</given-names></name>
<name><surname>Patel</surname><given-names>J.</given-names></name>
<name><surname>Newson</surname><given-names>R.</given-names></name>
<name><surname>Minelli</surname><given-names>C.</given-names></name>
<name><surname>Naghavi</surname><given-names>M.</given-names></name>
</person-group><article-title>Global and regional trends in COPD mortality, 1990&#x02013;2010</article-title><source>Eur. Respir. J.</source><year>2015</year><volume>45</volume><fpage>1239</fpage><lpage>1247</lpage><pub-id pub-id-type="doi">10.1183/09031936.00142414</pub-id><pub-id pub-id-type="pmid">25837037</pub-id>
</element-citation></ref><ref id="B39-tropicalmed-10-00056"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lai</surname><given-names>T.-C.</given-names></name>
<name><surname>Chiang</surname><given-names>C.-Y.</given-names></name>
<name><surname>Wu</surname><given-names>C.-F.</given-names></name>
<name><surname>Yang</surname><given-names>S.-L.</given-names></name>
<name><surname>Liu</surname><given-names>D.-P.</given-names></name>
<name><surname>Chan</surname><given-names>C.-C.</given-names></name>
<name><surname>Lin</surname><given-names>H.-H.</given-names></name>
</person-group><article-title>Ambient air pollution and risk of tuberculosis: A cohort study</article-title><source>Occup. Environ. Med.</source><year>2015</year><volume>73</volume><fpage>56</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1136/oemed-2015-102995</pub-id><pub-id pub-id-type="pmid">26514394</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="tropicalmed-10-00056-f001"><label>Figure 1</label><caption><p>Flowchart summarizing study methodology.</p></caption><graphic xlink:href="tropicalmed-10-00056-g001" position="float"/></fig><fig position="float" id="tropicalmed-10-00056-f002"><label>Figure 2</label><caption><p>Scatter plot showing correlation between air pollutants and respiratory disease incidence.</p></caption><graphic xlink:href="tropicalmed-10-00056-g002" position="float"/></fig><fig position="float" id="tropicalmed-10-00056-f003"><label>Figure 3</label><caption><p>Scatter plots showing correlation between pollutants and disease incidence after controlling for covariates (<bold>a</bold>) Air pollution against asthma incidence (<bold>b</bold>) Air pollution against COPD incidence (<bold>c</bold>) Air pollution against tuberculosis incidence.</p></caption><graphic xlink:href="tropicalmed-10-00056-g003" position="float"/></fig><fig position="float" id="tropicalmed-10-00056-f004"><label>Figure 4</label><caption><p>Comparison of disease incidence across high- and low-pollution periods using box plots, (<bold>a</bold>) Asthma incidence against AQI, ozone and NO<sub>2</sub> level (<bold>b</bold>) COPD incidence against AQI, ozone and NO<sub>2</sub> level (<bold>c</bold>) Tuberculosis incidence against AQI, ozone and NO<sub>2</sub> level.</p></caption><graphic xlink:href="tropicalmed-10-00056-g004" position="float"/></fig><table-wrap position="float" id="tropicalmed-10-00056-t001"><object-id pub-id-type="pii">tropicalmed-10-00056-t001_Table 1</object-id><label>Table 1</label><caption><p>Summary statistics for key variables.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Variable</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mean</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Std Dev</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Min</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Max</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">25th Percentile</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">75th Percentile</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AQI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21.68</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19.09</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.00</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">97.00</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.38</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32.00</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ozone (ppb)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.73</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.33</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49.16</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.93</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19.69</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO<sub>2</sub> (ppb)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.70</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.70</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35.33</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23.13</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthma (per 100k)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">558.40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">220.84</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">266.37</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1132.42</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">373.46</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">665.78</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD (per 100k)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">225.99</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">112.81</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.99</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">450.57</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">140.91</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">322.37</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis (per 100k)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">79.82</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">112.93</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.37</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">452.63</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">96.97</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GDP per capita (USD)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20,172.06</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20,648.17</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">758.30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">71,056.00</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2519.87</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27,576.82</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Health Expenditure (USD)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2191.69</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2811.98</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23.85</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12,051.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">120.43</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3030.46</td></tr></tbody></table></table-wrap><table-wrap position="float" id="tropicalmed-10-00056-t002"><object-id pub-id-type="pii">tropicalmed-10-00056-t002_Table 2</object-id><label>Table 2</label><caption><p>Pearson correlation result across all countries.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pollutant</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Disease</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Correlation</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AQI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.31975</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AQI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.34001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AQI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.376927</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.25681</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.007297</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.26938</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004815</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.376529</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO<sub>2</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.026574</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.78485</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO<sub>2</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.332522</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO<sub>2</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.40483</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table></table-wrap><table-wrap position="float" id="tropicalmed-10-00056-t003"><object-id pub-id-type="pii">tropicalmed-10-00056-t003_Table 3</object-id><label>Table 3</label><caption><p>Significant results of country-by-country Pearson correlation.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Country</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pollutant</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Disease</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Correlation</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Japan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AQI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.986431</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.013569</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Poland</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.977646</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.022354</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Poland</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.98662</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.013381</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thailand</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AQI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.9902</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.009804</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thailand</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.95613</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.04387</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Macedonia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AQI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.95414</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.045863</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Macedonia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AQI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.974516</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.025484</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Macedonia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.99894</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001062</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Germany</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AQI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.98862</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.011379</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cambodia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.997751</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002249</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cambodia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.96493</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.035073</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Costa Rica</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AQI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.985665</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.014335</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Costa Rica</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AQI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.9583</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.041697</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Costa Rica</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.99545</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004553</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Costa Rica</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.980057</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.019943</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">New Zealand</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AQI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.99361</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.006389</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">New Zealand</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.991269</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.008731</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Portugal</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AQI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.995486</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004514</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Portugal</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AQI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.964202</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.035798</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Portugal</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.9902</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.009804</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sweden</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.961</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.039002</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brazil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AQI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.95032</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.049679</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brazil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AQI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.982348</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.017652</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brazil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.991433</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.008567</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brazil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.99982</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000178</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mexico</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.985579</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.014421</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mexico</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.97464</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.025362</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chile</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AQI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.95829</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.041708</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Colombia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.96736</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.032645</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Colombia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.998609</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001391</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Colombia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.99968</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.00032</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">United States</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.99959</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.00041</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">United States</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.98343</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.01657</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Argentina</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AQI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.953342</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.046658</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Argentina</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.96261</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.037394</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Argentina</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.972659</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.027341</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Argentina</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.95793</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.042072</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Turkey</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.99576</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.004239</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">India</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.996541</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.003459</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">India</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.983482</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.016518</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ethiopia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.99897</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.00103</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pakistan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.99273</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.007273</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pakistan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.95445</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.045552</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">South Africa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.95643</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.043567</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">South Africa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.992937</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.007063</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nigeria</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.999815</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000185</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nigeria</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.99837</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.00163</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bangladesh</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AQI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.974085</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.025915</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bangladesh</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.998054</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001946</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bangladesh</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.96288</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.037117</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Angola</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AQI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.99351</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.00649</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Angola</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AQI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.993709</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.006291</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Angola</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.950886</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.049114</td></tr></tbody></table></table-wrap><table-wrap position="float" id="tropicalmed-10-00056-t004"><object-id pub-id-type="pii">tropicalmed-10-00056-t004_Table 4</object-id><label>Table 4</label><caption><p>Correlation between socioeconomic factors and disease incidence across all countries.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Socioeconomic Factor</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Disease</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Coeff (<italic toggle="yes">p</italic>-Value)</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GDP per capita</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.18 (0.12)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GDP per capita</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.77 (&#x0003c;0.001)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GDP per capita</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.55 (&#x0003c;0.001)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tobacco use</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.29 (0.01)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tobacco use</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.31 (0.005)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tobacco use</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.01 (0.95)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Health expenditure</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.26 (0.02)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Health expenditure</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.74 (&#x0003c;0.001)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Health expenditure</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.48 (&#x0003c;0.001)</td></tr></tbody></table></table-wrap><table-wrap position="float" id="tropicalmed-10-00056-t005"><object-id pub-id-type="pii">tropicalmed-10-00056-t005_Table 5</object-id><label>Table 5</label><caption><p>Significant results for country-by-country correlation between socioeconomic factors and disease incidence.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Country</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Confounder</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Disease</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Corr (<italic toggle="yes">p</italic>-Value)</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Turkey</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GDP/capita</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.99 (0.04)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Angola</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GDP/capita</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.99 (0.007)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ethiopia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GDP/capita</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.99 (0.01)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chile</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GDP/capita</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.99 (0.05)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Australia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GDP/capita</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.99 (0.02)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">New Zealand</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GDP/capita</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.99 (0.001)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bangladesh</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GDP/capita</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.99 (0.05)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Australia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tobacco use</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.99 (0.04)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Poland</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tobacco use</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.99 (0.003)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sweden</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tobacco use</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.99 (0.009)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">New Zealand</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tobacco use</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.99 (0.03)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">India</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Health expenditure</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.99 (0.01)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ethiopia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Health expenditure</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.99 (0.03)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thailand</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Health expenditure</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.99 (0.04)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bangladesh</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Health expenditure</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.99 (0.04)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bangladesh</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Health expenditure</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.99 (0.02)</td></tr></tbody></table></table-wrap><table-wrap position="float" id="tropicalmed-10-00056-t006"><object-id pub-id-type="pii">tropicalmed-10-00056-t006_Table 6</object-id><label>Table 6</label><caption><p>Multivariate regression analysis after controlling for covariates.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Pollution</bold>
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Asthma</bold>
<break/>
<bold>&#x003b2; (<italic toggle="yes">p</italic>-Value)</bold>
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<bold>COPD</bold>
<break/>
<bold>&#x003b2; (<italic toggle="yes">p</italic>-Value)</bold>
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Tuberculosis</bold>
<break/>
<bold>&#x003b2; (<italic toggle="yes">p</italic>-Value)</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AQI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;4.33 (0.56)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;7.34 (0.0087)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.29 (0.907)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ozone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.997 (0.552)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.05 (0.258)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.31 (0.0673)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.937 (0.211)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.26 (0.254)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;5.10 (&#x0003c;0.001)</td></tr></tbody></table></table-wrap><table-wrap position="float" id="tropicalmed-10-00056-t007"><object-id pub-id-type="pii">tropicalmed-10-00056-t007_Table 7</object-id><label>Table 7</label><caption><p>Analysis of variance in disease incidence during low- and high-pollution periods.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Disease</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pollution Level</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">F-Statistic (<italic toggle="yes">p</italic>-Value)</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AQI_level</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.45 (0.23)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE_level</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001 (0.98)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO<sub>2</sub>_level</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.92 (0.17)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AQI_level</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">42.84 (&#x0003c;0.001)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE_level</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.95 (0.09)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO2_level</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.32 (&#x0003c;0.001)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AQI_level</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38.35 (&#x0003c;0.001)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OZONE_level</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.27 (0.02)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuberculosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO<sub>2</sub>_level</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20.09 (&#x0003c;0.001)</td></tr></tbody></table></table-wrap></floats-group></article>